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ABBREVIATIONS 
2/3CS two- or three-component regulatory system 
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ABC ATP-binding cassette 
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G
-
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G
+
 Gram-positive bacteria 
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HPK histidine protein kinase  
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im immunity, immunity protein(s) or immunity gene(s) 
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LAB lactic acid bacteria 
Lb. Lactobacillus 
LB Luria-Bertani medium 
Lc. Lactococcus 
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M17GS M17 medium + 0.5% glucose + 0.5 M sucrose 
Nis nisin 
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1 INTRODUCTION 
 
Bacteriocins are ribosomally synthesised antimicrobial peptides (AMPs) produced by 
bacteria. Many lactic acid bacteria (LAB), for example Lactococcus, Lactobacillus, 
Leuconostoc, Carnobacterium, Enterococcus, and Pediococcus, have been reported to 
secrete AMPs against competing microorganisms. Because of their natural activity against 
foodborne pathogens and food spoilage bacteria, bacteriocins have been noticed as 
potential natural preservatives (Eijsink et al. 1998; Nes et al. 2001; Fimland et al. 2005). 
Since there is no agreement on the classification of LAB bacteriocins, common structural 
characteristics have been usually accepted to be the basis for sorting these AMPs 
(Klaenhammer 1993; Cotter et al. 2005b; Zouhir et al. 2010; Belguesmia et al. 2011). LAB 
bacteriocins which have been thoroughly studied and abundantly reported are those in class 
I (lantibiotics) and class II (unmodified bacteriocins). Bacteriocins of class II contain 20 to 
70 amino acids and permeabilise cell membrane to kill target cells. Unlike lantibiotics 
which contain unusual modified residues like lanthionines, class II bacteriocins do not 
undergo post-translational modifications (Ennahar et al. 2000; Drider et al. 2006; Nissen-
Meyer et al. 2009). 
 
Class II bacteriocins have been further divided into four subgroups, of which class IIa 
(pediocin-like) is comprised of bacteriocins sharing an N-terminal highly conserved 
sequence YGNGV/L (Drider et al. 2006; Nissen-Meyer et al. 2009). These peptides are the 
best characterised, and their activity against various Lactobacillus, Enterococcus, 
Leuconostoc, Clostridium, and especially the pathogenic Listeria strains have caught broad 
attention (Eijsink et al. 1998; Nissen-Meyer et al. 2009). Class IIa bacteriocins 
permeabilise the target cells by forming pores in the cytoplasmic membrane that 
subsequently leads to the depletion of the intracellular ATP pool, disturbance of the proton 
motif force and eventually the cell death (Herranz et al. 2001; Suzuki et al. 2005). After 
contacting the receptor molecule mannose phosphotransferase system (PTS) permease 
EIIt
Man
 on cell membrane, the N-terminal halves of these bacteriocins form a three-stranded 
anti-parallel β-sheet-like structure which stabilises the binding to the receptor on the target 
cell membrane (Kjos et al. 2011). Simultaneously, the helical C-termini penetrate into the 
receptor protein (Johnsen et al. 2005a). A hinge structure connects the two domains of a 
class IIa bacteriocin, facilitates the movement of either domain towards each other, and 
therefore mediates the pore formation (Johnsen et al. 2005a; Nissen-Meyer et al. 2009). 
Pores on the cell membrane result in the membrane leakage. Since such receptors 
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commonly exist on bacterial cells, these bacteriocins may also form pores on its producer 
cell membrane. Therefore, bacteriocin producing bacteria produce immunity proteins 
which bind to the bacteriocin-receptor complex from the cytosolic side of the cell 
membrane, and thus prevent the leakage of own membrane (Nissen-Meyer et al. 2009). 
 
Several Leuconostoc strains, such as Ln. carnosum LA54a, Ln. mesenteroides TA33a and 
Ln. gelidum UAL187, have been reported to produce different class II bacteriocins, namely 
leucocin A (class IIa), leucocin B (class IId) and leucocin C (class IIa) (Lewus et al. 1992; 
van Belkum and Stiles 1995; Papathanasopoulos et al. 1997). Ln. carnosum strain 4010 has 
been shown to produce both leucocin A and leucocin C; and because of its high 
antimicrobial activity and suitability in food, this strain is commercially available as a 
biopreservative culture in vacuum-packaged meat products (Budde et al. 2003). The strain 
is sold as preservative strain by the Danish starter company Chr. Hansen A/S.  
 
Although many class IIa bacteriocins including leucocin A have been studied extensively, 
the knowledge of leucocin C is limited. Only the amino acid sequence of the secreted 43-aa 
leucocin C peptide and its activity against Listeria has been published (Fimland et al. 
2002b). In addition, class IIa cross-immunity study showed that leucocin A immunity 
protein does not protect the cell from leucocin C, indicating that each leucocin has its own 
production-immunity system (Fimland et al. 2002a). None of the factors typically needed 
for class IIa bacteriocin production, i.e., dedicated translocators for secretion, a self-
protection (immunity) protein, and a regulatory system, has been reported for leucocin C 
production. As bacteriocins may one day be developed into drugs for medical use or 
additives in food and feed, studies on these antimicrobial bacteria like Ln. carnosum 4010 
provide knowledge about the weapons against pathogenic bacteria. 
 
In this work, the main objective was to study and characterise the genes needed for the 
production of antimicrobial peptide leucocin C in the industrial food bacterium Ln. 
carnosum 4010. The scientific literature focuses on the antimicrobial properties, in terms 
of bacteriocins produced by LAB, particularly class IIa bacteriocins. Heterologous 
expression of these peptides is also reviewed. The experimental section shows the 
localisation and identification of the genes needed for leucocin C production, as well as 
their explicit functions. Expression of leucocin C in a heterologous LAB host is also 
demonstrated for the development of new strains with improved antilisterial activity.  
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2 LITERATURE REVIEW 
 
2.1 Lactic acid bacteria 
 
Lactic acid bacteria (LAB) constitute a group of Gram-positive bacteria, which are non-
sporeforming, non-respiring cocci or rods, and produce lactic acid as the major end product 
from fermentation of carbohydrates (Axelsson 2004). LAB are widely used in food and 
feed fermentation and normally associated with (healthy) mucosal surfaces of humans and 
animals. Conventionally, the genera Lactobacillus, Lactococcus, Leuconostoc, 
Pediococcus, and Streptococcus form the core of the group. The more peripheral genera 
Aerococcus, Carnobacterium, Enterococcus, Oenococcus, Sporolactobacillus, 
Tetragenococcus, Vagococcus, and Weissella belonging to the order Lactobacillales are 
also regarded as LAB (Stiles and Holzapfel 1997). Leuconostocs are cocci in chains. They 
are commonly used as flavour starters in dairy products, but in refridgerated vaccum meat 
products, Leuconostoc species may cause food spoilage (Säde 2011). 
 
LAB are generally recognised as safe (GRAS) organisms. The use of LAB has been found 
throughout the history of food fermentation. Using fermentation in food preparation 
originally was to prevent food spoilage (Caplice and Fitzgerald 1999). In addition to giving 
foods desirable flavour, texture and nutrients, LAB also improve the safety of foods by 
inhibiting the competing spoilage and pathogenic bacteria (Daeschel 1989). LAB can grow 
in non-fermented foods as well, for example in vacuum-packaged meat products 
(Castellano et al. 2004). In this specific case, LAB such as Carnobacterium spp., 
Lactobacillus spp. and Leuconostoc spp. are the main spoilage microbes (Borch et al. 1996; 
Korkeala and Björkroth 1997; Settanni and Corsetti 2008). However, by co-culturing with 
other strains, the antimicrobial properties of these LAB can be promoted, while their 
spoilage effect can be minimised (Settanni and Corsetti 2008). 
 
Nowadays, safe foods with a long shelf-life or minimally processed products without 
chemical preservatives are favoured by modern consumers. Thus, biopreservation is an 
attractive option for food processors. Biopreservation is the use of natural microbes and 
their antimicrobial metabolites to increase safety and extend shelf-life of food (Stiles 1996). 
Due to their native antimicrobial properties, LAB have been used as protective cultures in 
the biopreservation of different food products, such as dairy, meat, fish, fruits and 
vegetables. These bacteria have been observed to increase the shelf-life of food 
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significantly without causing the sensory and structural changes in food (Budde et al. 2003; 
Cotter et al. 2005a; Castellano et al. 2010). LAB inhibit undesirable flora mainly by 
producing organic acids (Daeschel 1989; Cintas 2001). They also produce other 
antimicrobial substances like acetaldehyde, carbon dioxide, diacetyl, D-isomers of amino 
acids, fatty acids, hydrogen peroxide, and bacteriocins (Holzapfel et al. 1995; Cintas 2001).  
 
2.2 Bacteriocins from LAB 
 
As GRAS organisms, LAB have made noticeable contributions to food and feed 
fermentation. Their health promoting traits and their potency of producing AMPs attract 
great attention by researchers. AMPs present in innate immune systems of organisms 
protecting the hosts against invading organisms. The AMPs produced by bacteria are 
termed bacteriocins. They play an important role in the self-defence system of bacterial 
cells (Cotter et al. 2005a; Nes et al. 2007). Unlike conventional peptide antibiotics, 
bacteriocins are ribosomally synthesised, have relatively narrow spectrums of targeted 
bacteria, and inhibit against susceptible bacteria at very low (nanomolar) concentrations 
(Nes 2011). Some can inhibit nosocomial pathogens that are normally resistant to various 
antibiotics (Nes 2011). Bacteriocins can be introduced into foods in different ways. In 
fermentation, bacteriocin-producing LAB can substitute for part or all of the starter 
cultures. Bacteriocins can be added directly to foods as purified or semi-purified 
preparations (Cotter et al. 2005a). They can also be immobilised for the development of 
bioactive food packaging. In recent years, using bacteriocins in hurdle technology offers a 
novel approach for food preservation (Gálvez et al. 2007). 
 
The history of bacteriocins goes back to 1920s, and by that time a bacteriocin was referred 
to an AMP produced by Gram-positive bacteria (Jacob et al. 1953). In fact, Gram-positive 
and Gram-negative bacteria both produce bacteriocins (Riley and Gordon 1992; 
Klaenhammer 1993). The bacteriocins from G
+
 bacteria seem to have a relatively broader 
spectrum. In addition to killing bacteria from the same species of the bacteriocin producer, 
many of G
+
 bacteriocins also inhibit the growth of bacteria of other species and/or genera 
than the producer bacteria (Nes et al. 2007).   
 
Since the bacteriocin colicin was identified from Escherichia coli in 1920s, numerous 
microorganisms have been screened for their production of bacteriocins (Konisky 1982). In 
the past 20 years, there have been many studies focused on those produced by G
+
 bacteria, 
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particularly by LAB. According to their structures and targets, LAB bacteriocins may be 
sorted into two main groups (Cotter et al. 2005a). Other than the large heat-labile proteins 
(formerly class III), two major groups, the modified bacteriocins (class I) and the non-
modified (less modified) heat-stable bacteriocins (class II), cover the vast majority of the 
well investigated LAB bacteriocins (Nes 2011).  
 
A major group of class I bacteriocins is called lantibiotics. Lantibiotic peptides commonly 
produced by LAB are effective against G
+
 bacteria. They are characterised by post-
translational modifications, during which meso-lanthionine(s) or β-methyllanthionine(s) or 
both ring structures are formed (Kuipers et al. 2011). Lantibiotics kill bacteria mainly by 
forming voltage-dependent pores in cell membranes. The production of lantibiotics is 
usually regulated by a two-component regulatory system (2CS), though some lantibiotics 
like lactocin S have alternative regulatory systems (Kleerebezem et al. 2001; Rawlinson et 
al. 2005). 
 
A successful example of class I bacteriocins that have been used as peptide additive in 
food industry is nisin. This bacteriocin was approved by Joint FAO/WHO Expert 
Committee on Food Additives (JECFA) in 1969 and became commercial. Later on, nisin 
as food preservative was also legally accepted in European Union, the United States and 
many other countries. As the best studied lantibiotic peptide, nisin was first reported to be 
produced by Streptococcus lactis (Lc. lactis (Schleifer et al. 1985)) in milk fermentation in 
1920s (Rogers 1928; Rogers and Whittier 1928). It took about 50 years to determine the 
structure of nisin. Lantibiotic nisin contains five intermolecular lanthionine ring structures 
that are formed during post-translational modification (Gross and Morell 1971). Nisin has 
several variants, four of which are nisin A, F, Q, and Z differing by only a few amino acid 
residues produced by Lc. lactis strains (Twomey et al. 2002; Zendo et al. 2003; de 
Kwaadsteniet et al. 2008). Streptococcus uberis produces an additional variant, nisin U, 
which is 78% identical to nisin A and shorter in three amino acids than other nisin variants 
(Wirawan et al. 2006).  
 
The pore-forming activity of nisin is mediated by the cell wall precursor lipid II (Breukink 
et al. 1999). A stable pore complex consists of 8 nisin and 4 lipid II molecules. Two N-
terminal lanthionine rings of nisin allow the bacteriocin interact with the lipid II by 
forming a pyrophosphate cage, followed by the penetration of C-terminus into the 
membrane (van Heusden et al. 2002; Hsu et al. 2004). The interaction of lantibiotics which 
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share the pattern of the two N-terminal rings with nisin, for example epidermin, mutacins, 
and ericins, do not form pores on targeted cells but still possess high antibacterial activity 
by inhibiting the synthesis of the cell wall (Hasper et al. 2006). Some lantibiotics like nisin 
and subtilin also inhibit the outgrowth of Bacillus and Clostridium spores (Thomas et al. 
2002). 
 
Unlike lantibiotics, class II bacteriocins do not undergo post-translational modifications 
and thereby are structurally simpler. Generally, only genes encoding the bacteriocin, 
immunity protein and transporters are required for the production of class II bacteriocins. 
Synthesis of some bacteriocins is under the control of a two- or three-component 
regulatory system (2/3CS) which includes a sensor (histidine protein kinase, HPK), a 
response regulator (RR), and an induction factor (IF, peptide pheromone in 3CS) (Nes et al. 
1996; Nes and Eijsink 1999). Most bacteriocins are synthesised as a pre-peptide including 
an N-terminal leader peptide which is removed by the transporter during the exportation of 
bacteriocin. The most common signal peptides are double-glycine (GG) type leaders. The 
GG-leader is recognised and cleaved in secretion of many class II bacteriocins by ABC 
transporters (Nes et al. 2007).  
 
Class II bacteriocins can be further divided into four subgroups. Two conventional 
subgroups are the pediocin-like antilisterial class IIa and the two-peptide class IIb 
bacteriocins. The pediocin-like bacteriocins constitute a group of the most studied class II 
bacteriocins. They are characterised by their high activity against the food pathogen L. 
monocytogenes. Class IIa bacteriocins kill targeted cells by permeabilising the cell 
membrane, therefore disrupting the proton motive force of the cells and depleting the ATP 
pool. Biosynthesis of some class IIa bacteriocins, such as curvacin A, enterocin A, and 
sakacin P, is under the control of 3CS, while some others like divercin V41 are regulated 
by 2CS (Fimland et al. 2005; Drider et al. 2006).  
 
A commercialised example of unmodified bacteriocins from LAB is pediocin (also known 
as pediocin PA-1/AcH). Currently, pediocin is available as a commercial product named 
ALTA
TM
 2341 (Ennahar et al. 2000; Rodríguez 2002). The application of pediocin has 
been shown to reduce the levels of L. monocytogenes in various dairy products (Rodríguez 
2002). In raw meats, this bacteriocin can significantly lower the counts of L. 
monocytogenes and Clostridium perfringens (Rodríguez 2002; Nieto Lozano 2006). 
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2.3 Classification of bacteriocins 
 
The classification of bacteriocins is very controversial. The bacteriocins from LAB have 
been sorted based on their producers, molecular sizes, structures and/or mode of actions, 
etc. (Klaenhammer 1993; Jack et al. 1995; Cotter et al. 2005b; Zouhir et al. 2010). 
Klaenhammer (1993) divided LAB bacteriocins into four classes which are now commonly 
accepted. Class I bacteriocins (lantibiotics) were characterised as lanthionine-containing 
bacteriocins that undergo extensive post-translational modifications. Class II bacteriocins 
were heat-stable peptides and could be further divided into three subgroups. Class III was 
composed by large and heat-labile proteins, while class IV bacteriocins were defined as 
protein complexes composed of protein and chemical moieties (Klaenhammer 1993). This 
classification scheme was later modified. The fourth class was abolished, and criteria for 
dividing class II bacteriocins were changed on the basis of leader differences (Nes et al. 
1996).  Later, according to their specific secretion pathways, the number of subclasses of 
class II bacteriocins was expanded to six (van Belkum and Stiles 2000). Bacteriocins were 
once divided into only two main groups: class I (lanthionine-containing 
bacteriocins/lantibiotics) and class II (the non-lanthionine bacteriocins). In this proposal, 
the large heat-labile class III bacteriocins were renamed as bacteriolysins, i.e. non-
bacteriocin lytic proteins (Cotter et al. 2005a). Based on this classification scheme, class I 
lately covers all post-translationally modified bacteriocins from G
+
 bacteria, whereas the 
class II and bacteriolysins retained the same (Rea et al. 2011). In the latest review of 
bacteriocins produced by LAB, these AMPs were divided into four major groups. Unlike 
Klaenhammer‟s four-class system, in the latest classification, cyclic AMPs constitute the 
fourth group, and class II bacteriocins were grouped by their non-modified nature (Nes et 
al. 2007). Recently, a new structure-based classification was proposed. G
+
 bacteriocins 
were classified into 12 groups based on their amino acid sequences (Zouhir et al. 2010).  
 
In this chapter, LAB bacteriocins will be divided into 3 classes: class I (lantibiotics), class 
II (unmodified heat-stable bacteriocins), and class III (large heat-labile bacteriocins) based 
on recent classification schemes (Nes et al. 2007; Rea et al. 2011). 
 
2.3.1 Class I: lantibiotics 
 
Lantibiotics are small membrane-active peptides (<5 kDa) featured by post-translational 
modifications. These bacteriocins are ribosomally synthesised as inactive prepeptides. 
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After forming meso-lanthionine(s) and/or β-methyllanthionine(s), as well as other unusual 
amino acids and some dehydrated residues during post-translational modifications, they 
become biologically active (Kuipers et al. 2011). Nisin as the first identified lantibiotic has 
been the most studied. In the present classification, class I bacteriocins can be further 
divided into four subgroups on the basis of the modification pathway and antimicrobial 
activity (Rea et al. 2011). 
 
Lantibiotics like nisin, epidermin and Pep5 are considered as type I lantibiotics which 
undergo modifications by two enzymes, LanB for aa dehydration and LanC for lanthionine 
ring formation (Willey and van der Donk 2007). On the other hand, type II lantibiotics, 
such as lacticin 481, mersacidin, and actagardin are modified by only one bifunctional 
enzyme, LanM (Siezen et al. 1996). Two-peptide lantibiotics like lacticin 3147 and 
haloduracin are also included in this class (Ryan et al. 1996; McClerren et al. 2006). Type 
III lantibiotics were described as lanthionine-containing peptides without antimicrobial 
activity. SapB, SapT and AmfS belong to type C, as their modification enzymes share 
homology to the C-terminal domain of LanM (Meindl et al. 2010; Kuipers et al. 2011; Rea 
et al. 2011). The type IV lantibiotics possess novel lanthionine synthetases called LanL. 
They have clear lantibiotic characteristics in their structures and biosynthetic means, but 
their antimicrobial activities are still unknown (Goto 2010; Rea et al. 2011). 
 
2.3.2 Class II: unmodified bacteriocins 
 
Class II bacteriocins are heat-stable bacteriocins with molecular masses less than 10 kDa. 
Unlike lantibiotics, these bacteriocins do not undergo post-translational modifications. 
Class II unmodified bacteriocins were originally subdivided into 3 groups: IIa pediocin-
like, IIb two-peptide, and IIc thiol-activated bacteriocins (Klaenhammer 1993). Since then, 
there have been several alternative classifications about class II bacteriocins, but all of 
them agreed and identified the two major subclasses, i.e. the pediocin-like antilisterial 
bacteriocins (class IIa) and two-component bacteriocins (class IIb) (Nes et al. 1996; 
Eijsink et al. 2002; Drider et al. 2006).  In addition to the two established subclasses, class 
IIc cyclic bacteriocins and class IId non-pediocin-like single linear peptides were 
suggested and retained in a review of class II bacteriocins (Cotter et al. 2005a; Nissen-
Meyer et al. 2009). In this chapter, the four-subdivision classification will be present 
(Table 1). 
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At least 34 one-peptide antilisterial bacteriocins are included in class IIa and also known 
as pediocin-like bacteriocins (Table 2, p19). In this group, bacteriocins, such as leucocin A 
(LeuA) (Hastings et al. 1991), mesentericin Y105 (Hechard et al. 1992) and pediocin 
(Henderson et al. 1992; Marugg et al. 1992; Nieto Lozano et al. 1992) have very similar 
amino acid sequences and contain conserved YGNGV/L “pediocin box” motif and a C-
terminal disulfide bridge formed by two cysteines. According to sequence similarities in 
the C-terminal region, IIa bacteriocins may be further sorted into three or four subgroups 
(Fimland et al. 2005; Nissen-Meyer et al. 2009). The class IIb currently includes 16 
unmodified members (Nissen-Meyer et al. 2009). Class IIb bacteriocins such as 
lactococcin G, plantaricins, and lactocin 705 are composed of two different peptides, both 
of which are necessary for the full antimicrobial activity (Oppegård et al. 2007). Class IIc 
bacteriocins for example enterocin AS-48, gassericin A and reutericin 6 are cyclic 
bacteriocins. In their structures, the N- and C-termini are linked by a covalent bond (Cotter 
et al. 2005a). Class IId represents various heterogeneous one-peptide linear non-pediocin-
like bacteriocins. They do not fit to any existing classification schemes. The best 
characterised example of this group is lactococcin A produced by Lc. lactis strains. Like 
class IIa bacteriocins, it permeablises targeted cell membrane by binding to the mannose 
phosphotransferase permease (Holo et al. 1991; Diep et al. 2007). 
 
Table 1. Classification of class II bacteriocins produced by lactic acid bacteria. 
Class Description Examples Producer Reference 
IIa pediocin-like bacteriocins, 
antilisterial activity 
Leucocin A Ln. gelidum UAL 187 Hastings et al. 1991 
Pediocin P. acidilactici PAC-1.0 Henderson et al. 1992 
IIb two-peptide bacteriocins, 
pore-forming activity 
Lactococcin G Lc. lactis LMG 2081 Nissen-Meyer et al. 
1992 
Lactacin F Lb. johnsonii VPI 11088 van Belkum et al. 1991 
IIc circular bacteriocins Lactococcin 972 Lc. lactis IPLA 972 Martinez et al. 1999 
IId non-pediocin-like one-
peptide bacteriocins  
Enterocin Q E. faecium L50 Cintas et al. 2000 
Leucocin B Ln. mesenteroides TA33a Papathanasopoulos et 
al. 1998 
 
2.3.3 Class III: large heat-labile bacteriocins 
 
Klaenhammer (1993) defined class III LAB bacteriocins as large (>30 kDa) heat-labile 
proteins often with enzymatic activity. In their domain-type structures, different domains 
function differently for translocation, binding to receptor, and antimicrobial activity (Cotter 
et al. 2005a). The class has been suggested to have another name: bacteriolysin, since these 
proteins were considered to degrade the targeted cell wall leading to cytolysis. However, 
helveticin J does not kill bacteria by lytic effect (Joerger and Klaenhammer 1986). 
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Therefore, they should not be literally called bacteriolysins. Up to date, five class III 
bacteriocins produced by LAB have been identified and characterised. In addition to 
helveticin J from Lb. helveticus, they are zoocin A from Streptococcus zooepidermicus 
(Simmonds et al. 1997), enterolysin A from Enterococcus faecalis (Hickey et al. 2003), 
millericin B from Streptococcus milleri (Beukes et al. 2000) and linocin M18 produced by 
Brevibacterium linens (Valdes-Stauber and Scherer 1994). 
 
2.4 Class IIa bacteriocins 
 
Class IIa bacteriocins are probably the most important and well-studied bacteriocins 
among the unmodified AMPs. Many LAB strains produce class IIa bacteriocins. These 
bacteriocins are also called pediocin-like bacteriocins, which is derived from the first 
characterised bacteriocin in this class, pediocin (Biswas et al. 1991; Nieto Lozano et al. 
1992). Class IIa bacteriocins are regarded to possess a narrow antimicrobial spectrum. 
They are particularly effective against the foodborne pathogen Listeria strains. Recently, 
some class IIa bacteriocins have been found to be effective against both G
+
 and G
-
 bacteria, 
such as Campylobacteri jejuni and Escherichia coli O157:H7 (Drider et al. 2006; Stern et 
al. 2006; Line et al. 2008; Svetoch et al. 2008).  
 
Class IIa bacteriocins are heat-stable, cationic, partly amphiphilic and/or hydrophobic and 
small (<10 kDa) peptides with amino acid residues ranging from 37 to 48. These 
bacteriocins contain a highly conserved hydrophilic part in the N-terminal region and a 
variable C-terminal half which is comparatively hydrophobic (Figure 1) (Nissen-Meyer et 
al. 2009). In this group, curvacin A (Tichaczek 1993), LeuA (Hastings et al. 1991), 
mesentericin Y105 (Hechard et al. 1992), pediocin (Henderson et al. 1992; Marugg et al. 
1992; Nieto Lozano et al. 1992) and sakacin P (Tichaczek et al. 1994) are the first 
bacteriocins that have been found and characterised. So far, 34 bacteriocins have been 
identified in this group (Belguesmia et al. 2011).  
 
18 
 
 
Figure 1. The structure and orientation of class IIa bacteriocins in membrane without receptor. The C-
terminal hairpin structure is stabilised by (a) a disulfide bridge formed between two cysteines, e.g., pediocin, 
or (b) tryptophan near the C-end in the membrane interface, e.g., leucocin C. Trp, tryptophan. S-S, disulfide 
bridge. Hinge, Asp-17. Adapted from Nissen-Meyer et al. (2009). 
 
Bacteriocins in this group possess the conserved “pediocin-box” motif (YGNGV/L) in 
their highly similar N-terminal region, but differ in the C-terminal halves. These two 
regions are connected by a hinge structure, which is at the highly conserved Asp-17 
residue, providing structural flexibility for class IIa bacteriocins (Uteng et al. 2003). The 
diversity occurred in the hydrophobic C-termini offers a basis for further dividing these 
bacteriocins into four subclasses (Table 2) (Nissen-Meyer et al. 2009). The recently 
identified bacteriocin pentocin 31-1 has only been partly sequenced, but its incomplete 
amino acid sequence contains the YGNGV/L motif showing that this bacteriocin belongs 
to group IIa (Zhang et al. 2009). Bacteriocins in subgroup 2 are composed of fewer 
residues, because of shorter C-termini (Table 2). In the N-terminal region, there is a 
conserved disulfide bridge formed by two cysteines. In addition, another Cys-Cys disulfide 
bridge is also found in the C-termini of some class IIa bacteriocins, stabilising the hairpin 
structure. Peptides in subgroup 3 as well as enterocin SE-K4 and carnobacteriocin B2 in 
subgroup 4 exceptionally have neither the conserved tryptophan at the C-tails, nor the 
cysteine residues to form the C-terminal disulfide bridge (Table 2).  
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Table 2. Multiple sequence alignment of class IIa (pediocin-like) bacteriocins. Adapted from Nissen-Meyer et al. (2009). 
Class IIa bacteriocins Amino acid sequence of mature peptide Reference 
Subgroup 1                      .        .         .         .         .  
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
Divergicin M35 
Coagulin 
Divercin V41 
Enterocin A 
Pediocin 
Sakacin P 
Listeriocin 743A 
Avicin A 
Mundticin L 
Mundticin KS 
Enterocin CRL35 
Piscicocin CS526 
Piscicolin 126 
Sakacin 5X 
Leucocin C 
Ubericin A 
    TKYYGNGVYCNSKKCWVDWGTAQGCID--VVIGQLGGGIPGKGKC 
     KYYGNGVTCGKHSCSVDWGKATTCIINNGAMAWATGGHQGTHKC 
    TKYYGNGVYCNSKKCWVDWGQASGCIGQTVVGGWLGGAIPG--KC 
TTHSGKYYGNGVYCTKNKCTVDWAKATTCIAGMSIGGFLGGAIPG--KC 
     KYYGNGVTCGKHSCSVDWGKATTCIINNGAMAWATGGHQGNHKC 
     KYYGNGVHCGKHSCTVDWGTAIGNIGNNAAANWATGGNAGWNK 
     KSYGNGVQCNKKKCWVDWGSAISTIGNNSAANWATGGAAGWKS 
     TYYGNGVSCNKKGCSVDWGKAISIIGNNSAANLATGGAAGWKS 
     KYYGNGLSCNKKGCSVDWGKAIGIIGNNSAANLATGGAAGWKS 
     KYYGNGVSCNKKGCSVDWGKAIGIIGNNSAANLATGGAAGWKS 
     KYYGNGVSCNKKGCSVDWGKAIGIIGNNSAANLATGGAAGWKS 
     KYYGNGLSXNKKGXTVDWGTAIGIIGNNAAANXATGGAAGXNK 
     KYYGNGVSCNKNGCTVDWSKAIGIIGNNAAANLTTGGAAGWNKG 
     KYYGNGLSCNKSGCSVDWSKAISIIGNNAVANLTTGGAAGWKS 
     KNYGNGVHCTKKGCSVDWGYAWTNIANNSVMNGLTGGNAGWHN 
   KTVNYGNGLYXNQKKXWVNWSETATTIVNNSIMNGLTGGN 
Tahiri et al. 2004 
Le Marrec et al. 2000 
Metivier et al. 1998 
Aymerich et al. 1996 
Henderson et al. 1992; Marugg et al. 1992 
Tichaczek et al. 1994 
Kalmokoff et al. 2001 
Birri et al. 2010 
Feng 2009 
Kawamoto et al. 2002 
Bennik et al. 1998 
Yamazaki et al. 2005 
Bhugaloo-Vial et al. 1996; Jack et al. 1996 
Vaughan et al. 2001 
Fimland et al. 2002b 
Heng et al. 2007 
Subgroup 2 
17 
18 
19 
20 
21 
22 
Leucocin A 
Mesentericin Y105 
Lactococcin MMFII 
Plantaricin 423 
Plantaricin C19 
Sakacin G 
     KYYGNGVHCTKSGCSVNWGEAFSAGVHRLANGGNGFW 
     KYYGNGVHCTKSGCSVNWGEAASAGIHRLANGGNGFW 
     TSYGNGVHCNKSKCWIDVSELETYKAGTVSNPKDILW 
     KYYGNGVTCGKHSCSVNWGQAFSCSVSHLANFGHGKC 
     KYYGNGLSCSKKGCTVNWGQAFSCGVNRVATAGHGKX 
     KYYGNGVSXNSHGCSVNWGQAWTXGVNHLANGGHGVC 
Hastings et al. 1991 
Fleury et al. 1996 
Ferchichi et al. 2001 
van Reenen et al. 2003 
Atrih et al. 2001 
Simon et al. 2002 
Subgroup 3 
23 
24 
25 
Carnobacteriocin BM1 
Curvacin A 
Enterocin P 
    AISYGNGVYCNKEKCWVNKAENKQAITGIVIGGWASSLAGMGH 
    ARSYGNGVYCNNKKCWVNRGEATQSIIGGMISGWASGLAGM 
   ATRSYGNGVYCNNSKCWVNWGEAKENIAGIVISGWASGLAGMGH 
Quadri et al. 1995 
Tichaczek 1993 
Cintas et al. 1997 
Subgroup 4 
26 
27 
28 
29 
30 
31 
Bacteriocin 31 
Bacteriocin RC714 
Bacteriocin T8 
Carnobacteriocin B2 
Enterocin SE-K4 
Penocin A 
    ATYYGNGLYCNKQKCWVDWNKASREIGKIIVNGWVQHGPWAPR 
    ATYYGNGLYCNKEKCWVDWNQAKGEIGKIIVNGWVNHGPWAPR 
    ATYYGNGLYCNKEKCWVDWNQAKGEIGKIIVNGWVNHGPWAPRR 
     VNYGNGVSCSKTKCSVNWGQAFQERYTAGINSFVSGVASGAGSIGRRP 
    ATYYGNGVYCNTQKCWVDWSRARSEIIDRGVKAYVNGFTKVLG 
     KYYGNGVHCGKKTCYVDWGQATASIGKIIVNGWTQHGPWAHR 
Tomita et al. 1996 
Del Campo et al. 2001 
De Kwaadsteniet et al. 2006 
Quadri et al. 1995 
Eguchi et al. 2001 
Diep et al. 2006 
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The YGNGV/L „pediocin box‟ is marked (bold), the leucine residue (L), odd, and uncertain amino acids (X) are marked as bold and red. Names of the six newly identified class IIa 
bacteriocins are in red (Rea et al. 2011). The sequence similarity (conserved residues) in the peptides of different subgroups are shaded with different colours. Shading patterns are 
listed as following: flexible hinge at the conserved Asp/Asn-17 (green), Trp and Met (black), Val (pink), Ile (violet), Thr and Arg (teal), Cys (grey). 
Table 2. Continued 
 
  
Unclassified 
32 
33 
34 
Enterocin E50-52 
Pentocin 31-1 
Bacteriocin OR-7 
   TTKNYGNGVCNSVNWCQCGNVWASCNLATGCAAWLCKLA 
   VIADYGNGVRXATLL 
   KTYYGTNGVHCTKNSLWGKVRLKNMKYDQNTTYMGRLQDILLGWATGAFGKTFH 
Svetoch et al. 2008 
Zhang et al. 2009 
Stern et al. 2006 
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2.4.1 Mode of action  
 
Class IIa bacteriocins are active against various Carnobacterium, Clostridium, 
Enterococcus, Lactobacillus, Lactococcus, Leuconostoc, Listeria, and Pediococcus strains. 
These bacteriocins kill bacteria by forming pores in the cytoplasmic membrane. The 
targeted cell membrane is consequently permeabilised, leading to the depletion of the 
intracellular ATP pool, the disturbance of the proton motif force, and eventually the cell 
death (Chikindas et al. 1993; Herranz et al. 2001; Suzuki et al. 2005). On one hand, the 
highly conserved hydrophilic part in the N-terminal region facilitates the interaction 
between the bacteriocin and the negatively charged phospholipid-containing membrane 
and/or acidic bacterial cell wall. On the other hand, the variable C-terminal half which is 
comparatively hydrophobic permits the bacteriocin permeabilise the targeted cell 
membrane (Nissen-Meyer et al. 2009). 
 
Circular dichroism (CD) spectroscopy and nuclear magnetic resonance (NMR) analysis on 
the structure of several class IIa bacteriocins showed that these bacteriocins only formed 
specific structures when they exposed to a membrane-mimicking matrix (Fregeau 
Gallagher et al. 1997; Watson et al. 2001; Uteng et al. 2003; Haugen et al. 2005). After 
contacting with the targeted cell membrane, the N-terminal half forms an S-shaped β-sheet 
structure stabilized by a conserved disulfide bridge, while the C-terminus concomitantly 
forms a hairpin structure. The C-terminal hairpin is comprised of an amphiphilic α-helix 
and an extended C-tail folding back to the central helix (Uteng et al. 2003; Johnsen et al. 
2005a). In some cases, such as divercin V41, enterocin A and pediocin, the hairpin 
structure is stabilised by a disulfide bridge formed by two cysteine residues. However, 
most class IIa bacteriocins do not contain the two-cysteine frame, therefore the central 
tryptophan (Trp-18) and the C-terminal tryptophan stabilise the hairpin structure  (Figure 1, 
p18) (Nissen-Meyer et al. 2009). The two domains of a class IIa bacteriocin are connected 
by a flexible hinge that permits the movement of either domain towards each other and the 
penetration of the C-terminal hairpin into the membrane central part (Uteng et al. 2003).  
 
The N- and C-terminal domains may have independent functions in the mode of action of 
class IIa bacteriocins. By exchanging domains between several class IIa bacteriocins, 
hybrid bacteriocins were constructed and investigated (Johnsen et al. 2005a). The active 
hybrid bacteriocins displayed similar target-cell specificities with the parental bacteriocin 
which donated the C-terminal hairpin but quite different from N-terminal donator (Johnsen 
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et al. 2005a). The results showed that the conserved N-terminal β-sheet domain mediates 
the binding of the bacteriocin to the targeted cell membrane surface, but the C-terminal 
part is responsible in the determination of the target-cell specificity. The specificity seemed 
to rely on the interactions between the C-termini of the class IIa bacteriocins and the lipids 
and/or proteins in the hydrophobic core of the targeted cell membrane (Johnsen et al. 
2005a).  
 
In this interaction, one protein expressed by the targeted cell has been suggested to be the 
targeted molecule (bacteriocin receptor): the membrane-associated mannose 
phosphotransferase system (PTS) permease, named EIIt
Man
 (Hechard et al. 2001; Ramnath 
et al. 2004; Xue et al. 2005; Drider et al. 2006). In both G
+
 and G
-
 bacteria, PTSs are 
involved in transport and phosphorylation of carbohydrates (Postma et al. 1993). In L. 
monocytogenes, EIIt
Man
 is one of the main glucose transporters (Stoll and Goebel 2010). 
The mannose PTS permeases are composed of IIA, IIB, IIC and IID four domains, 
arranged in two to four subunits. The IIA and IIB are cytoplasmic domains responsible for 
phosphorylation, while the IIC and IID membrane domains function in transport (Postma 
et al. 1993). In L. monocytogenes the IIA and IIB domains of the EIIt
Man
 are fused as a 
single subunit complex (Drider et al. 2006). 
 
The EIIt
Man 
permease is known to be encoded by the mptACD operon. By inactivating this 
operon by directed mutagenesis in L. monocytogenes and E. faecalis, the mutant strains 
displayed high resistance to the class IIa bacteriocin mesentericin Y105 (Dalet et al. 2001; 
Hechard et al. 2001). Heterologous expression of mptACD operon of L. monocytogenes in 
an insensitive Lc. lactis rendered the sensitivity of the resultant Lc. lactis strain to 
divergent class IIa bacteriocins (Ramnath et al. 2004). Meanwhile, separate expression of 
each gene encoding fused IIAB, IIC and IID domains specified that the IIC itself is 
sufficient in the target recognition by class IIa bacteriocins (Ramnath et al. 2004). The 
membrane-located IIC and IID have both been shown to be necessary for the receptor 
(Diep et al. 2007). Later, co-expression of IIC and IID conferred strong and similar 
sensitivity to class IIa bacteriocins with the host which only produces IIC, confirming that 
IIC is the main determinant of specificity (Kjos et al. 2010). An N-terminal extracellular 
loop comprised of 40 aa in this IIC domain was then identified to be the major determinant 
of the species-specificity. The loop thus may function as an interaction site for the 
recognition of class IIa bacteriocins (Kjos et al. 2010). The function of IID is not yet 
known, but it might indirectly interact with the bacteriocin during the pore formation. In a 
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latest review, the IID was considered to have a structural function helping IIC to fold 
correctly in the membrane (Figure 2, p26) (Kjos et al. 2011). 
 
The receptor recognition and the subsequent pore formation require serial steps and 
different regions of a class IIa bacteriocin. The N-terminal β-sheet of a class IIa bacteriocin 
firstly binds to the extracellular loop of the IIC domain of EIIt
Man
. The C-terminal hairpin 
of the bacteriocin then inserts into the membrane resulting in the helix-helix interactions 
between the bacteriocin central α-helix and transmembrane IIC and/or IID of the mannose 
permease. Subsequently, the insertion of bacteriocin renders structural changes in the 
EIIt
Man
 contributing to the opening of the permease, i.e., the formation of pores (Figure 2, 
p26) (Kjos et al. 2011).  
 
2.4.2 Bacteriocin immunity 
 
In order to protect the producers from being killed by their own bacteriocins, bacteria have 
a self protective system termed immunity. The immunity of bacteriocins is accomplished 
by the protective proteins that are co-produced with the bacteriocins. According to 
BACTIBASE, among all 34 class IIa bacteriocins, more than 20 have been shown to have 
putative immunity proteins (Drider et al. 2006). 
 
An immunity protein is encoded by an immunity gene which is located immediately 
downstream from its cognate class IIa bacteriocin structural gene usually in the same 
operon. Transcription of both bacteriocin and its cognate immunity genes is co-regulated in 
bacterial cells, as immunity can be shut down concomitantly (Eijsink et al. 1998). For 
example, sakacin P producer Lb. sake LTH673 has a stable bacteriocin-free phenotype. 
The strain has been shown to become sensitive to its own bacteriocin and several other 
class IIa bacteriocins (added in culture), when the cells stopped producing sakacin P 
(Eijsink et al. 1998).  
 
The immunity proteins, which sizes range from 81 to 115 amino acids, share only a little 
similarities in their amino acid sequences, although class IIa bacteriocins are quite similar 
to each other in the sequences. However, common sequence motifs may still be identified 
based on comparison studies, and three subgroups have been consequently proposed 
(Fimland et al. 2002a). The subgroup B contains immunity proteins of bacteriocins like 
sakacin P, listeriocin 743A and piscicolin 126, which belong to the same subgroup of class 
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IIa bacteriocins without C-terminal disulfide bridges (Table 2, p19). In these immunity 
proteins, there is a noticeable motif (SNIRYGY) in the C-terminal end. Another two 
immunity proteins in this subgroup are orfβ3-im and divT2-im. They share some 
consensus motifs with the other immunity proteins but do not have corresponding AMPs 
(Fimland et al. 2005).  
 
The NMR solution and crystal structures of immunity proteins for carnobacteriocin B2 
(subgroup C), enterocin A and pediocin (subgroup A) showed that there is a bundle 
comprised of four antiparallel helix and a flexible C-tail in the structure of these proteins 
(Dalhus et al. 2003; Sprules et al. 2004; Johnsen et al. 2005b). Later, the structure of 
subgroup B immunity protein (piscicolin 126-im) was shown to have the conserved four-
helix bundle but relatively shorter and less flexible C-terminal part (Martin-Visscher et al. 
2008). Structural studies on hybrid immunity proteins proposed that the C-terminal parts of 
the immunity proteins determine the immunity and specific recognition of the C-terminal 
hairpin of class IIa bacteriocins (Johnsen et al. 2004; Johnsen et al. 2005a). Moreover, 
piscicolin 126 immunity protein contains a C-terminal hydrophobic pocket comprising 
residues that are highly conserved in subgroup B immunity proteins (Martin-Visscher et al. 
2008). As hydrophobic interactions are normally involved in the interactions between 
proteins, this region may be crucial in the interaction between the bacteriocin and its 
immunity protein (Martin-Visscher et al. 2008). 
 
Heterologous expression of an immunity gene in sensitive bacteria makes the bacteria less 
sensitive to the corresponding class IIa bacteriocin, confirming the function of the 
immunity protein (Fimland et al. 2005). The differences in the sequences among immunity 
proteins suggest these proteins are highly specific to their cognate bacteriocins. For 
example, LeuA immunity protein expressed in E. faecalis and Lb. sake provided maximum 
protection against its own bacteriocin but not against leucocin C (Fimland et al. 2002a). 
Nevertheless, expression of an immunity gene in a heterologous host may provide 
protection not only to its corresponding bacteriocin but also to some other similar class IIa 
bacteriocins (Eijsink et al. 1998). The concept of cross-immunity was also proposed based 
on the evidence that certain immunity proteins are most likely to protect against 
structurally related bacteriocins (Fimland et al. 2002a). For example, sakacin P immunity 
protein (sakP-im) from group B is able to protect cells against pediocin, leucocin C and its 
own bacteriocin sakacin P. All three belong to the same subclass (subgroup 1) of class IIa 
bacteriocins. However, sakP-im-producing bacteria were susceptive to enterocin A, which 
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is also in the subgroup 1, even though enterocin A immunity protein protected against 
sakacin P.  
 
Class IIa bacteriocins are secreted to extracellular environment, but their immunity 
proteins retain inside of the cells. So the intracellular immunity proteins may hardly have 
direct interaction with their bacteriocins, especially because the C-terminal hairpin 
structure of class IIa bacteriocins is too small to penetrate through the targeted cell 
membrane (Figure 1, p18 and Figure 2) (Quadri et al. 1995). Besides, the function of 
immunity protein has been found to be strain-dependent (Johnsen et al. 2005a). Therefore, 
instead of direct binding to the bacteriocins, the immunity proteins may interact with a 
receptor protein which varies in different strains (Figure 2 and Figure 3, p30) (Fimland et 
al. 2002a; Johnsen et al. 2004).  
 
As mentioned before, the EIIt
Man
 permease functions as the receptor for class IIa 
bacteriocins. This receptor was also suggested to mediate immunity mechanism of the cells. 
The immunity proteins have been shown to bind the mannose permease strongly only 
when the bacteriocin also connects the permease (Diep et al. 2007). The flexible C-
terminal part of the immunity protein has been shown to recognise the C-terminal half of 
the cognate bacteriocin, but no direct physical contact has been found between the two 
proteins (Sprules et al. 2004; Johnsen et al. 2005b). The immunity proteins do not prevent 
the formation of bacteriocin-receptor complex by binding to the receptors competitively. 
They also do not interact directly with the bacteriocins or cause structural changes of the 
bacteriocins. Instead, these proteins interact with the cytoplasmic parts of the IIC and/or 
IID domains of EIIt
Man
, thus blocking the pore formed by the receptor-bacteriocin complex 
and interfering the membrane leakage (Figure 2) (Kjos et al. 2011). As the C-termini of 
class IIa bacteriocins vary to a large extent, the pores formed by these bacteriocins may 
have different characteristics, such as acidity, size and hydrophobicity. The sequential 
variations in the immunity proteins, therefore, may allow the immunity proteins fit and 
block the pores formed by the cognate bacteriocins (Figure 2, 3 p30) (Kjos et al. 2011). As 
a side effect, glucose transport is also blocked, leading to the reduced growth on glucose. 
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Figure 2. Proposed model of action of class IIa bacteriocins (a) and immunity (b). The N-terminal β-sheet of the bacteriocin (red) binds to an extracellular loop (a) of the EIIt
Man IIC 
domain (left). Then, the C-terminal helix interacts with transmembrane helices of the IIC and/or IID proteins (right) causing conformational changes, thereby resulting in the pore 
formation and eventually cell death. In immune cells (b), the bacteriocin mediates the same conformational changes, but the pore is blocked by a specific immunity protein (dark blue) 
which tightly binds to EIIt
Man-bacteriocin complex. Adapted from Kjos et al. (2011). 
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2.4.3 Biosynthesis  
 
Class IIa bacteriocins are commonly found to be encoded by genes on plasmids, but there 
are a few exceptions. For example, genes for enterocin A (Aymerich et al. 1996), divercin 
V41 (Metivier et al. 1998), sakacin P (Huhne et al. 1996), and carnobacteriocin B2 and 
BM1 (Quadri et al. 1997b) are localised on bacterial chromosomes. Yet, despite of the 
different loci of the bacteriocin genes, a class IIa bacteriocin usually need 2-8 genes for its 
production. The genes: 1) a structural gene, 2) an immunity gene, 3) one or two genes for 
ATP-binding cassette (ABC) transporter, and 4) a gene encoding accessory protein, have 
been shown to involve in class IIa bacteriocin production, secretion of functional peptides, 
and protection of the producer cells. The structural gene encodes an inactive pre-
bacteriocin containing an N-terminal leader peptide (Nes et al. 1996; Ennahar et al. 2000). 
The corresponding immunity gene, usually in the same operon, is co-transcribed along 
with the bacteriocin precursor. The ABC transporters and their accessory proteins that are 
responsible for the secretion of the bacteriocins are encoded by a cluster of genes usually 
localised in different operon than the bacteriocin/immunity operon (Klaenhammer 1993; 
Ennahar et al. 2000).  
 
The structural gene and the genes at flanking regions are often organised in one or a few 
operons being transcribed independently (Fimland et al. 2005). Commonly, genes involved 
in the production of class IIa bacteriocins are arranged in three operons: one for the 
structural and immunity genes, the second for transporter genes, and the third for 
regulation of bacteriocin production. However, bacteriocins like pediocin, plantaricin 423 
and coagulin only have one operon containing all four genes for the production (Ennahar et 
al. 2000). Due to particular DNA rearrangements, the divercin V41 operon has particular 
gene organisation (Metivier et al. 1998). 
 
The leader peptides of most class IIa pre-bacteriocins are of GG-type. However, several 
class IIa bacteriocins, for example, listeriocin 743A (Kalmokoff et al. 2001), bacteriocin 
31 (Tomita et al. 1996) and enterocin P (Cintas et al. 1997) have been found to have a sec-
type leader. These bacteriocins are assumed to be secreted by sec-dependent exporting 
pathway.  
 
The GG-type leaders can be recognised by the dedicated ABC transporters (Ennahar et al. 
2000). The ABC transporters for production of class IIa bacteriocins have an extra N-
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terminal cysteine protease domain that is used to cut off the leader after the GG-motif 
(Figure 3, p30) (Havarstein et al. 1995). The GG-leader is consequently removed by the 
ABC transporters during transmembrane translocation, and the mature bacteriocin is 
subsequently secreted (Havarstein et al. 1995). By exchanging the leader peptides, it is 
possible to heterologously express class IIa bacteriocin via another secretion system, which 
may be more efficient (Ennahar et al. 2000).  
 
In addition, the existence of leader peptides in bacteriocin precursors also protects the 
producer at the cytoplasmic side of the cell membrane. Studies on pre-LeuA (Fregeau 
Gallagher et al. 1997), pre-mesentericin Y105 (Biet et al. 1998) and pre-carnobacteriocin 
B2 (Quadri et al. 1997a) revealed reduced activities to sensitive cells compared with their 
mature peptides. The pre-bacteriocin maintains inactive and interferes in the interactions 
between the bacteriocin and the target cell membrane (Drider et al. 2006). In the leader 
peptide of pre-bacteriocin, an amphiphilic α-helix structure containing 10 amino acids has 
been identified. The minor helix folds back onto the central α-helix of the bacteriocin 
without causing other structural changes. This helix-helix structure interferes in the 
interaction between the central part of bacteriocin and the receptor on targeted cell 
membrane, thereby diminishing its antimicrobial activity (Sprules et al. 2004). 
 
2.4.4 Regulation of biosynthesis  
 
The productions of some class IIa bacteriocins are regulated. Bacteriocins such as curvacin 
A, enterocin A, and sakacin P are transcriptionally regulated by quorum sensing, a 
mechanism for monitoring the population density. Quorum sensing mechanisms for 
regulating the production of class IIa bacteriocins are usually termed as three component 
regulatory systems (Figure 3, p30) (Fimland et al. 2005; Drider et al. 2006). The three 
components in 3CS are encoded by a set of genes encoding 1) peptide pheromone as an 
induction factor (IF), 2) a transmembrane histidine protein kinase (HPK), and 3) a 
cytosolic response regulator (RR) (Ennahar et al. 2000).  
 
Like associated bacteriocins, the IF is also ribosomally synthesised at low level as a 
prepeptide with a GG-type leader peptide, which is subsequently processed and secreted by 
the dedicated ABC transporter (Nes and Eijsink 1999; Ennahar et al. 2000). The IF 
functions as a signal in the induction of the transcription of particular genes. In such 
regulatory mechanism, IF production requires low constitutive expression. Concomitant 
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with the increase of cell density, IF concentration gradually accumulates to a certain level 
that triggers the autoinduction loop. The excess IF then activates HPK. Consequently, the 
conserved His residue at the cytosolic side of HPK is autophosphorylated. The HPK-P is 
then able to transfer its phosphate group onto the conserved Asp residue of corresponding 
RR. The RR-P therefore can bind to specific promoters in order to stimulate the 
transcription of the bacteriocin genes (Nes and Eijsink 1999).  
 
Some class IIa bacteriocins like divercin V41 from Carnobacterium divergens V41 are 
produced under the regulation of 2CS (Metivier et al. 1998). The 2CS regulatory system is 
composed of HPK and RR but not peptide pheromone. Additionally, it is worth mentioning 
that carnobacteriocins B2 and BM1 have both 2CS and 3CS for their regulations (Saucier 
et al. 1995; Quadri et al. 1997b).  
 
In addition to the quorum sensing mediated regulation, the syntheses of several class IIa 
bacteriocins are liable to environmental factors, for example temperature, ionic strength 
and pH. The optimum temperature for bacteriocin synthesis has been reported to be near 
20 ºC, and the bacteria generally tend to stop producing bacteriocins when the temperature 
is 37 ºC or higher (Cintas et al. 1997; Fimland et al. 2000). Most bacteriocins show 
decreased activity at 37 ºC or higher temperature. However, pediocin has been shown to 
remain active at higher temperature, because of its disulfide bridge at C-terminal region 
stabilising the bacteriocin structure (Fimland et al. 2000; Kaur et al. 2004). The influence 
of environmental temperature on the synthesis seems to overwhelm the innate quorum 
sensing regulatory mechanisms (Diep et al. 2000). For example, the production of sakacin 
A, which is naturally regulated by the quorum-sensing mechanism, ceases at about 37 ºC, 
even though the inducer peptide has been added into the growth medium (Nes and Eijsink 
1999). 
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Figure 3. The production of class IIa bacteriocin: three-component regulatory system, biosynthesis, secretion, and immunity. CM, cell membrane. Im, immunity protein. EIIt
Man, 
mannose PTS permease, class IIa bacteriocin receptor. IIC and IID are the two EIIt
Man domains that interact with class IIa bacteriocins. Adapted from Ennahar et al. (2000). 
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2.5 Heterologous expression of class IIa bacteriocins 
 
Due to their potential for food biopreservation, bacteriocins produced by LAB have drawn 
broad attention, though natural defects of the producers limit the use of bacteriocins. First 
of all, most of bacteriocin producing LAB kill bacteria within narrow range, or the 
production of bacteriocins is not efficient. Further, the ability of producing bacteriocins by 
LAB can be spontaneously lost. Besides, LAB may not survive in certain food conditions, 
or they may cause unwanted flavours in foods. Therefore, heterologous expression of 
bacteriocins facilitates manipulation of bacteriocin gene expression, development of starter 
strains with increased antimicrobial properties, and functional studies on recombinant 
AMPs (Rodríguez et al. 2003).  
 
In this chapter, the heterologous expression will focus on secretion of class IIa bacteriocins, 
which can be achieved by 1) cloning the entire bacteriocin operon into the desired strain or 
2) exchanging leader peptides with either GG-type- or sec-dependent leader (Cintas et al. 
2011).  
 
Expression of native bacteriocin genes 
Pediocin ped operon from Pediococcus acidilactici PAC1.0 has been cloned into E. coli 
and the sensitive strain P. pentosaceus PPE1.2. The results showed that pediocin was 
correctly produced and secreted by the hosts (Marugg et al. 1992). Usually, heterologous 
production of bacteriocins with this approach is at lower level than that of the native 
producer. By increasing the copy number of the recombinant pediocin plasmid and using 
the lactococcal constitutive promoter P32, the production of pediocin in Lc. lactis LL108 
could be increased to the wild-type level (Chikindas et al. 1995). Nevertheless, 
abovementioned strains were not applicable in dairy industry. Therefore, Lc. lactis MM210 
was then used as the production host, and the subsequent pediocin-producing strain 
together with other native cheese starters evidently retarded the growth of Listeria in 
experimental cheese (Buyong et al. 1998). In a later study, the intact pediocin operon was 
cloned into a nisin-inducible plasmid and functionally expressed in S. thermophilus, Lc. 
lactis and Lb. casei (Renye and Somkuti 2010). 
 
Enterocin A is naturally produced by Enterococcus faecium DPC1146 under the control of 
3CS. Cloning of all genes and regulatory regions permitted the production of enterocin A 
and its induction factor by E. faecalis OG1X. However, bioactive enterocin A could also 
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be produced in E. faecalis OG1X and L. lactis IL1403, when only the structural (entA), 
immunity (entI), transporter and accessory genes (entTD) were expressed under the control 
of the promoter P32 (O'Keeffe et al. 1999). 
 
Exchanging leader peptides 
Most of the LAB bacteriocins require a dedicated processing and secretory system, i.e., 
ABC transporter and an accessory protein (Ennahar et al. 2000). The ABC transporter 
recognises its dedicated leader peptide and cut it off when the bacteriocin is secreted 
(Ennahar et al. 2000). The leaders and corresponding transporters are similar in most class 
II bacteriocins and some lantibiotics (Franke et al. 1999; Rodríguez et al. 2003). Therefore, 
exchanging leader peptides and/or dedicated transportation system allows the heterologous 
production of bacteriocins in LAB hosts.  
 
Pediocin from P. acidilactici and lactococcin A from Lc. lactis WM4 both have GG-type 
leaders and their dedicated secretory systems. Gene encoding mature pediocin was cloned 
into the lactococcin translocation apparatus as a fusion with the lactococcin signal 
sequence, resulting in the secretion of functional pediocin (Horn et al. 1998). As Lc. lactis 
is naturally resistant to pediocin, the immunity gene pedB is not necessary for the 
production. However, co-expressing pedB increased the pediocin production to the level of 
the parental strain (Arques et al. 2008).  
 
In a recent study, the papA gene encoding mature pediocin was fused to usp45 signal 
sequence after a constitutive promoter P45 and a nisin promoter PnisZ in a lactococcal 
expression vector. The resulting plasmid was then transferred into Lc. lactis NZ9000 with 
nisin regulatory genes nisK and nisR integrated into the chromosome. As a result, bioactive 
pediocin was produced by Lc. lactis with and without nisin induction, though the 
production level was higher with nisin induction (Li et al. 2011). 
 
Active pediocin has also been secreted by Bifidobacterium longum, E.coli and Lb. reuteri 
with bifidobacterial α-amylase signal sequence (Moon et al. 2005; Eom et al. 2010). In 
addition, pediocin has been fused to the precursor of the maltose-binding protein (MBP) 
and secreted as a part of the resulting chimeric protein via sec-dependent secretory system. 
The signal peptide of MBP precursor is recognised by the sec-secretory system of E. coli 
and cut off during the secretion resulting in active MBP-pediocin protein (Miller et al. 
1998).  
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The production of mesentericin Y105 (MesY105) in Ln. mesenteroides requires mesYI 
operon, encoding pre-MesY105 with GG-leader and the immunity protein, and the 
mesCDE operon for secretion. Cloning the two operons allowed the production of 
MesY105 in E. coli and Ln. mesenteroides. By replacing the gene encoding mature 
MesY105 with the gene for mature pediocin, the latter could be produced via MesY105 
secretion mechanism in Ln. mesenteroides (Morisset and Frere 2002). 
 
Another means that has been actively studied for heterologous production of bacteriocins is 
the general secretory pathway. In prokaryotes, sec-dependent pathway is a commonly 
existing universal protein export mechanism (Pugsley 1993).  
 
Enterocin P (EntP) is a sec-dependent bacteriocin from E. faecium P13 (Herranz and 
Driessen 2005). The EntP gene along with its immunity gene were cloned and expressed 
via sec-dependent pathway in E. coli, but the production level was comparatively lower 
than that of the native producer (Gutierrez et al. 2005) However, the EntP signal peptide of 
E. faecium P13 could allow the efficient production of EntP in several Lc. lactis strains, 
including the nisin producer Lc. lactis DPC5598. Introduction of the EntP encoding 
plasmid in Lc. lactis DPC5598 allowed the co-production of both EntP and nisin (Gutierrez 
et al. 2006).  
 
Divergicin A is another example of a bacteriocin exported by the general secretion 
pathway. By fusing divergicin A signal sequence with gene encoding mature 
carnobacteriocin B2, the bacteriocin could be secreted via the general secretory pathway 
by several heterologous hosts, like C. piscicola strains and Lc. lactis IL1403 (McCormick 
et al. 1996). Heterologous production of MesY105 was also achieved in E. coli DH5α by 
replacing its own leader with the divergicin A signal peptide, although the general 
secretory pathway seemed not to be as efficient as the bacteriocin‟s own secretion system 
(Biet et al. 1998).  
 
In addition, yeast can also be used to produce bacteriocins. By inserting pediocin structural 
gene into an expression cassette in Saccharomyces cerevisiae, the bioactive bacteriocin 
was successfully produced to reduce spoilage bacteria in yeast-based fermentations. 
However, because of the attachment of bacteriocin on yeast cells, the concentration of free 
pediocin in the yeast culture supernatant was undesirably low (Schoeman et al. 1999). 
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2.6 Leucocin C and other Leuconostoc bacteriocins 
 
Bacteriocins produced by Leuconostoc species are termed leucocins or mesentericins, 
usually characterised as heat-stable and class II bacteriocins. However, the nomenclature 
of leucocins lacks systematic agreement. For example LeuA has been called with at least 9 
different names, including some confusing ones, such as leucocin B TA11a and leucocin C 
LA7a (Table 3). Several Leuconostoc strains like Ln. carnosum Ta11a, Ln. gelidum UAL 
187 and Ln. paramesenteroides La7a seem to produce more than one bacteriocin, as they 
have been named differently, but these leucocins are actually either identical or nearly 
identical with LeuA (Hastings et al. 1991; Felix et al. 1994; Hastings 1996). 
 
Because of their structural and functional disparities, leucocins are not sorted in one class 
or subclass according to the commonly accepted classification described in chapter 2.3 
(Klaenhammer 1993). The most studied leucocin is the class IIa bacteriocin LeuA 
(Hastings et al. 1991). Leucocin S (previously called leuconocin S) belongs to class IV in 
Klaenhammer‟s classification (Lewus 1992; Klaenhammer 1993). Leucocin B-TA33a (31 
aa) is a class IId bacteriocin sharing 62% identity with mesenterocin 52B, a 32 aa 
bacteriocin (Corbier et al. 2001; Nissen-Meyer et al. 2009). The name leucocin D-La54a is 
now abolished and replaced by carnocin 54 which classification has not been mentioned 
but which kills Listeria strongly dependent on pH (Schillinger et al. 1995).  
 
Among leucocins, A-, B- and C-type bacteriocins are widely present. Ln. carnosum TA33a 
produces all three leucocins, whereas Ln. carnosum 4010 and Ln. mesenteroides 6 have not 
been shown to produce leucocin B but only A and C (Papathanasopoulos et al. 1998; 
Vaughan et al. 2001; Budde et al. 2003).  
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Table 3. Bacteriocins produced by Leuconostoc strains. 
Name Producer Description Reference 
Leucocin A 
Leucocin 6A Ln. mesenteroides 6 Nearly identical to leucocin A UAL 187 (S12X) Vaughan et al. 2001 
Leucocin A 4010 Ln. carnosum 4010 Partially sequenced, 33 aa Budde et al. 2003 
Leucocin A (ΔC7) Ln. pseudomesenteroides QU 15 Deﬁcient in seven C-terminal residues compared with leucocin A UAL 187 Sawa et al. 2010 
Leucocin A QU 15 Ln. pseudomesenteroides QU 15 Identical to leucocin A UAL 187 Sawa et al. 2010 
Leucocin A TA33a Ln. mesenteroides TA33a Identical to leucocin A UAL 187 Papathanasopoulos et al. 1998 
Leucocin A UAL 187 Ln. gelidum UAL 187 24 aa leader and 37 aa mature peptide, 
mmnmkptesyeqldnsaleqvvggKYYGNGVHCTKSGCSVNWGEAFSAGVH
RLANGGNGFW 
Hastings et al. 1991 
Leucocin B TA11a Ln. carnosum TA11a 7 aa different from leucocin A UAL 187 in leader peptide, mature part 
identical to leucocin A  
Felix et al. 1994 
Leucocin C LA7a Ln./W. paramesenteroides LA7a Identical to leucocin B TA11a Hastings 1996 
Leucocin E TA33a Ln. mesenteroides TA33a Identical to leucocin A Hastings 1996 
 
Leucocin B 
Leucocin B TA33a Ln. mesenteroides TA33a 31 aa, class IId Papathanasopoulos et al. 1998 
 
Leucocin C 
Leucocin C Ln. mesenteroides 6 43 aa of mature peptide, unknown leader sequence, 
KNYGNGVHCTKKGCSVDWGYAWTNIANNSVMNGLTGGNAGWHN 
Fimland et al. 2002b 
Leucocin 6C Ln. mesenteroides 6 Partially sequenced, 35 aa Vaughan et al. 2001 
Leucocin 7C Ln. mesenteroides 7 Nearly identical to leucocin C TA33a (A22W), partially sequenced, 30 aa Vaughan et al. 2001 
Leucocin 10C Ln. mesenteroides 10 Nearly identical to leucocin C TA33a (A22W), partially sequenced, 35 aa Vaughan et al. 2001 
Leucocin B 4010 Ln. carnosum 4010 Identical with leucocin C-Ta33a, partially sequenced, 39 aa Budde et al. 2003 
Leucocin C TA33a Ln. mesenteroides TA33a Partially sequenced, 36 aa, identical to leucocin C Papathanasopoulos et al. 1998 
 
Others 
Leucocin D La54a Ln. carnosum La54a Aka carnocin 54, antilisterial Keppler et al. 1994 
Leucocin F10 Ln. carnosum F10 pH and α- amylase sensitive Parente et al. 1996 
Leucocin Hα Ln. MF215B Two peptide bacteriocin Blom 1999 
Leucocin J Ln. sp. J2 Aka leuconocin J Choi 1999 
Leucocin K Ln.  paraplantarum C7 52 aa Accession  number:  AF420260 
Leucocin N Ln. pseudomesenteroides QU 15 Class IId, same operon as LeuQ Sawa et al. 2010 
Leucocin Q Ln. pseudomesenteroides QU 15 Class IId, same operon as LeuN Sawa et al. 2010 
Leucocin S Ln. paramesenteroides OX Aka leuconocin S, α-amylase sensitive Lewus 1992 
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Bacteriocins produced by Leuconostoc but not named as leucocin 
Mesentericin ST99 Ln. mesenteroides ST99  Todorov and Dicks 2004 
Mesentericin Y105 Ln. mesenteroides Y105 Class IIa, 24 aa leader and 37 aa mature peptide, 
mtnmksveayqqldnqnlkkvvggKYYGNGVHCTKSGCSVNWGEAASAGIH
RLANGGNGFW 
Hechard et al. 1992 
Mesenterocin 5 Ln. mesenteroides UL5  Daba et al. 1991 
Mesenterocin 52A Ln. mesenteroides FR52 Identical to mesentericin Y105 Revol-Junelles et al. 1996 
Mesenterocin 52B Ln. mesenteroides FR52 Class IId Revol-Junelles et al. 1996 
Mesenterocin E131 Ln. mesenteroides E131 Identical to mesentericin Y105 Xiraphi et al. 2008 
Mesenterocin Y Ln. mesenteroides E131 Partially purified peptide  Zdolec et al. 2008 
Mesenterocin Ln. mesenteroides OZ. Chromosome-associated Osmanagaoglu and Kiran 2011 
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Leucocin C (LecC), a member of class IIa bacteriocins, has been found to be produced by 
several Leuconostoc strains, such as Ln. carnosum 4010 and Ln. mesenteroides TA33a. 
Interestingly, Ln. mesenteroides 7 and 10 seemed to produce only one type peptide which 
amino acid sequence was nearly identical to LecC, but the C-terminal of this peptide could 
not be well identified (Vaughan et al. 2001). LecC shares high homology in the primary 
amino acid structure with bacteriocins in subgroup 1 of class IIa. Like other class IIa 
bacteriocins, it renders target cell death by permeabilising the cell membrane, and shows 
noticeably specific activity against several LAB and Listeria (Nes et al. 2001).  
 
The earlier study published the incomplete LecC sequence consisting only 36 aa. However, 
the contradiction between the calculated molecular mass according to the sequence and the 
mass spectrometry results (4597-4598 Da) revealed that more residues were missing 
(Papathanasopoulos et al. 1997). Five years later, the complete amino acid sequence of 
mature LecC was determined, and its theoretical molecular weight (4596 Da) was closely 
consistent with the previous experimental value (Papathanasopoulos et al. 1997; Fimland 
et al. 2002b). Pediocin-like bacteriocins are translated as inactive precursors with N-
terminal leader peptide mediating exportation of the bacteriocins (Fimland et al. 2005). 
However, since LecC was isolated as secreted peptide from culture supernatant, it was 
unable to identify the sequence of LecC leader peptide in the previous study (Fimland et al. 
2002b). Since then, its leader sequence has never been identified. 
 
As described in chapter 2.4.4 (P28), immunity proteins of class IIa bacteriocins confer 
immunity against several other members in this group than its corresponding bacteriocin. 
However, it is not the case for leucocin producer. Ln. mesenteroides strains 6 and TA33a, 
and Ln. carnosum 4010 have been found to produce both leucocins A and C, but previous 
experimental results showed the LeuA-im producer was still killed by LecC 
(Papathanasopoulos et al. 1998; Vaughan et al. 2001; Fimland et al. 2002a; Budde et al. 
2003). Therefore, there should be a LecC dedicated self-protective system in LecC native 
producers protecting against this bacteriocin. However, no such system has been published. 
 
Up to now, the sequence of LecC gene has not been revealed, and there are still no hints 
for the other genes that are conventionally required for the production of IIa bacteriocins in 
any published studies. 
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3 AIMS OF THE STUDY 
 
Since LeuA immunity protein does not provide immunity against LecC, Ln. carnosum 
4010 needs a LecC-dedicated immunity system to survive from its own bacteriocin. The 
necessity for an immunity gene indicates that there would also be other LecC-dedicated 
genes, and that LecC is a bacteriocin with independent production system. The aims of this 
study were to localise the gene cluster for LecC production in Ln. carnosum 4010 genome, 
to characterise the genes and to demonstrate their explicit functions. In addition to the 
structural and immunity genes, LecC gene cluster could also contain a transporter gene(s) 
and/or regulatory genes. This study also aimed to produce LecC in a heterologous host Lc. 
lactis by exchanging lecC own signal sequence with lactococcal signal sequence of usp45 
for development of new strains with improved antilisterial activity. 
  
4 MATERIALS AND METHODS 
 
4.1 Bacterial strains, plasmids and culture conditions 
 
Bacterial strains used in this study are listed in Table 4. BD Difco™ Agar (Granulated) 
(Difco, Becton Dickinson and Company Sparks, MD, USA) was used as solidifying agent 
for culture media, 1.5% for agar plates, and 0.75% for soft-agar. Ln. carnosum 4010 was 
grown on M17 (Oxoid Ltd. Basingstoke, UK) agar or in broth supplemented with 0.5% 
(w/v) glucose (M17G) at 30 °C, or on brain heart infusion (BHI; Lab M Ltd. Topley House, 
UK) agar at 30 °C. Lc. lactis strains were grown on M17G or BHI agar or broth at 30 °C. E. 
coli was grown in Luria-Bertani (LB; 10 g/l Bacto™ Tryptone, 5 g/l Bacto™ Yeast Extract, 
10 g/l NaCl) agar or broth at 37 °C with shaking. L. monocytogenes was grown in BHI 
agar or broth at 30 °C with shaking. Lb. rhamnosus was grown on Man-Rogosa-Sharpe 
(MRS; Lab M Ltd. Topley House, UK) agar at 37 °C. Lb. plantarum was grown in MRS 
broth at 30 °C. 
 
Plasmids used in this study are listed in Table 5. To maintain and select plasmids in Lc. 
lactis, media were supplemented with 50 IU nisin /ml (Nis
50
). Erythromycin was used at 
final concentrations of 250 µg/ml for E. coli and 5 µg/ml for Listeria. 
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Table 4. Bacterial strains used in this study. 
Bacterial strain Relevant properties Reference/source 
Ln. carnosum 4010 Wild-type leucocin C producer Budde et al. 2003 
Lb. plantarum 
WHE 92 
Wild-type pediocin producer Ennahar et al. 1996 
Lb. rhamnosus 1/6 Wild-type strain, pepR promoter Varmanen et al. 1998,Valio 
Ltd., FI 
E. coli TG1 Transformation host strain  Sambrook and Russell 2001 
E. coli ECO758 TG1 carrying lecI-plasmid pLEB732 This study 
E. coli SAA594 TG1 carrying vector pTF1 Takala, unpublished 
Lc. lactis MG1363 Transformation host strain for lecCI cloning Gasson 1983 
Lc. lactis NZ9000 Transformation host, MG1363 with nisK and nisR 
integrated into the chromosome; nisin-inducible strain 
Kuipers et al. 1998 
Lc. lactis LAC360 NZ9000 carrying vector pLEB690 Li et al. 2011 
Lc. lactis LAC361 NZ9000 carrying pediocin-plasmid pLEB691 Li et al. 2011 
Lc. lactis LAC405 MG1363 carrying lecC-plasmid pLEB728 This study 
Lc. lactis LAC406 MG1363 carrying lecCI-plasmid pLEB729 This study 
Lc. lactis LAC407 MG1363 carrying lecI-plasmid pLEB730 This study 
Lc. lactis LAC408 NZ9000 carrying lecCI-plasmid pLEB729 This study 
Lc. lactis LAC409 NZ9000 carrying lecC-plasmid pLEB728 This study 
Lc. lactis LAC411 MG1363 carrying vector pLEB690 This study 
Lc. lactis LAC412 MG1363 carrying pediocin-plasmid pLEB691 This study 
L. monocytogenes 
WSLC 1018 
Transformation host strain for lecI cloning, indicator, 
LecC sensitive 
A gift from prof. Martin 
Loessner, ETH Zürich, CH 
L. monocytogenes 
MUU22 
WSLC 1018 carrying vector pTF1 This study 
L. monocytogenes 
MUU23 
WSLC 1018 carrying lecI-plasmid pLEB732 This study 
 
Table 5. Plasmids used and constructed in this study. 
Plasmid Relevant properties Reference/source 
pLEB688 Lc. lactis food-grade expression vector, P45 promoter, 3466 
bp, NisR 
Li et al. 2011; P45, Koivula et al. 
1991 
pLEB690 Lc. lactis food-grade secretion vector harbouring 
lactococcal SSusp45, P45 and PnisZ promoters, 3746 bp, Nis
R 
Li et al. 2011; SSusp45, van 
Asseldonk et al. 1990 
pLEB691 papA fused with usp45 in pLEB690 Li et al. 2011 
pLEB728 lecC without its own secretion signal in pLEB690 (NaeI) This study 
pLEB729 lecCI without lecC secretion signal in pLEB690 (NaeI) This study 
pLEB730 lecI in pLEB688 (NcoI/SmaI) This study 
pLEB732 lecI with pepR promoter from Lb. rhamnosus 1/6 in pTF1 
(EcoRI/SmaI) 
This study 
pTF1 E. coli/Listeria shuttle vector, 3043 bp, ErmR; pLEB579 
carrying multiple cloning site from pBluescript 
Takala and Fieseler, unpublished; 
pLEB579, Beasley et al. 2004 
pTMT46 Leucocin A and its immunity genes  Takala, unpublished 
 
4.2 DNA isolations 
 
4.2.1 Isolation of plasmids from Leuconostoc 
 
Ln. carnosum 4010 plasmid DNA was isolated according to Anderson and McKay rapid 
method of isolating large plasmids from Lactococcus with some modifications (Anderson 
and McKay 1983).  The recipes of required solutions are listed in Appendix 1.  
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Ln. carnosum 4010 was grown overnight in 3 ml M17G at 30 °C. From the o/n culture, 1 
ml was inoculated into 50 ml M17G and incubated at 30 °C for 14 h. The cells were 
collected by centrifugation (10000 rpm, 4 min, JA-14, Beckman Avanti™ J-251). Pelleted 
cells were resuspended in 3.8 ml buffer 1 and divided into two 15 ml Falcon tubes. 
Lysozyme was dissolved in buffer 2 with final concentration of 20 mg/ml. Then, for each 
tube, 485 µl of lysozyme solution and 25 µl of mutanolysin (5000 U/ml) were added in the 
cell suspension. Lysozyme and mutanolysin degrade the cell wall. The mixture was 
incubated at 37 °C for 1 h. After incubation, 240 µl of buffer 3 and 138 µl of buffer 4 were 
consecutively blended into each tube. SDS in buffer 4 dissolves cell membranes and 
therefore lyses the cells. If the cells have been lysed, the solution should become clear and 
viscous after adding buffer 4. The solution was then incubated at 37 °C for 10 min in order 
to achieve complete lysis. After cell lysis, the tubes were vortexed for 1 min. DNA was 
denatured with 138 µl of freshly prepared 3.0 N NaOH and the tubes were inverted gently 
for 10 min. The blend was neutralised by adding 250 µl of buffer 5 followed by 3 min 
gentle mixing. After mixing, 360 µl of 5.0 M NaCl was blended. In highly concentrated 
salt solution, chromosomal DNA and proteins are precipitated, while plasmid DNA retains 
in soluble form. Phenol (5 ml) was added into each tube and thoroughly mixed. After 
centrifugal separation (10000 rpm, 5 min), the upper aqueous layer was transferred into 
new Falcon tube. Phenol extraction was repeated if upper layer was still turbid. The clear 
aqueous layer was subsequently extracted with 5 ml of chloroform-isoamyl alcohol (24:1) 
and centrifuged. The resultant upper layer was transferred and precipitated with 1 volume 
of isopropanol in freezer for 1 h. The precipitated plasmid DNA was collected by 
centrifugation (10000 rpm, 25 min). Pelleted DNA was washed with 4 ml 70% ethanol. 
The DNA was collected by centrifugation (10000 rpm, 5 min) and thoroughly dried before 
dissolving in H2O. RNA in the obtained DNA sample was degraded by RNase (0.1 mg/ml). 
 
4.2.2 Isolation of plasmids from E. coli and Lactococcus 
 
E. coli strains carrying plasmids were grown in 3 ml LB broth with appropriate antibiotic 
selection. Cells were collected by centrifugation. Vector and constructed plasmids were 
isolated from corresponding E. coli strains with EZNA plasmid mini kit (Omega Bio-tek, 
GA, USA) according to supplier‟s instructions.  
 
Recombinant Lactococcus strains were grown in 5 ml M17G broth with appropriate 
antibiotic selection. Cells were collected by centrifugation. Plasmids in these strains were 
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isolated with EZNA plasmid mini kit with the following modification. After resuspending 
Lactococcus cells in solution I, lysozyme (20 mg/ml) was added. The mixture was 
incubated at 37 °C for 1 h. After incubation, the mixture was further processed according 
to supplier‟s instructions. 
 
4.3 DNA manipulations 
 
4.3.1 Enzymatic reactions 
 
Restriction enzymes used in this study were from Fermentas (Vilnius, Lithuania), New 
England Biolabs (Ipswich, MA, USA), and Promega (Madison, WI, USA). Enzymes and 
DNA samples were mixed and incubated at the optimal reaction temperature in the buffers 
recommended by the suppliers.  
 
For DNA insert ligation into vector DNA, reaction mixture was prepared as followed: 300 
ng linear vector DNA, 5:1 molar ratio of insert DNA over vector, 3 μl 10 × T4 DNA ligase 
buffer, 0.5 μl T4 DNA ligase, and H2O to total volume 30 μl.  For linear DNA self-ligation, 
reaction was in the following condition: 50 ng linear DNA, 5 μl 10 × T4 DNA ligase buffer, 
1 μl T4 DNA ligase, and H2O to total volume 50 μl. Reactions were incubated at room 
temperature for 30 min, and the enzyme was heat inactivated at 65 °C for 10 min. 
 
In order to prevent self-ligation of vectors, calf intestine alkaline phosphatase (CIP, New 
England Biolabs) was used to remove 5‟ phosphate from linear vector DNA. CIP treatment 
was performed at 37 °C for 30 min. Since CIP cannot be heat inactivated, CIP treated DNA 
was purified with the PCR clean-up system kit (Promega).  
 
As primers are supplied non-phosphorylated, PCR fragments do not contain phosphate at 
their 5‟-ends. Therefore, to ensure ligation of PCR products, T4 polynucleotide kinase 
(PNK, New England Biolabs) was used for phosphorylation. The PCR products were 
phosphorylated in T4 DNA ligase buffer (New England Biolabs) and incubated at 37 °C 
for 30 min. PNK treated DNA samples were directly used in ligation without kit 
purification. 
 
Enzymes and their cognate buffers, and reaction conditions recommended by the 
manufacturers are listed in Appendix 2. 
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4.3.2 Polymerase Chain Reaction (PCR) 
 
Fragments for screening, cloning or sequencing in this study were amplified by standard 
PCR (Sambrook and Russell 2001) with either Taq DyNAzyme™ II DNA polymerase or 
Phusion High-Fidelity DNA polymerase (Finnzymes, Espoo, Finland) in Eppendorf 
Mastercycler (Hamburg, Germany). Taq PCRs were carried out in reaction volume of 25 
or 50 µl with the following conditions: 1 × DyNAzyme™ buffer, 0.2 mM dNTPs 
(Fermentas, Finnzymes), 0.5 µM forward primer, 0.5 µM reverse primer, 0.5 or 1 U 
DyNAzyme™ II DNA polymerase (Fermentas), and 0.5 or 1 μl template DNA. In order to 
ensure high fidelity of DNA amplification for cloning or sequencing, Phusion DNA 
polymerase with proofreading function was used. Phusion PCRs were performed in 
reaction volume of 50 µl with the following condition: 1 × Phusion HF buffer (Finnzymes), 
0.2 mM dNTPs (Fermentas), 0.5 µM forward primer, 0.5 µM reverse primer, 1 U Phusion 
High-Fidelity DNA polymerase (Finnzymes), and 1 μl template DNA. PCR programmes 
used in this study are listed in Appendix 3. Primers used in PCR are listed in Table 6 (p45). 
 
Inverse PCR (iPCR) was carried out like standard PCR. The DNA template for iPCR was 
firstly restricted with enzyme, purified with PCR clean-up kit (Promega), and self-ligated. 
The ligation mixture was used in iPCR without purification. 
 
4.3.3 DNA kit purifications and concentration measurement 
 
Linear DNA samples either extracted from agarose gel or directly from PCR or enzymatic 
treatments were purified with Wizard® SV Gel and PCR clean-up system kit (Promega). 
 
The concentrations of DNA samples, including PCR products and plasmids were measured 
by NanoDrop-1000 Spectrophotometer (Thermo Fisher Scientific Inc., Waltham, MA, 
USA).  
 
4.4 Transformations 
 
The transfer of DNA into bacteria was carried out by electroporation with Bio-Rad 
GenePulser device (Bio-Rad Laboratories, Richmond, CA, USA). Buffers and media used 
for electroporation were listed in Appendix 4. 
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4.4.1 Lc. lactis transformation 
 
Lc. lactis strains were grown overnight in M17G broth at 30 °C. From the o/n culture, 500 
µl was inoculated into pre-warmed (at 30 °C) 50 ml M17GS supplemented with 1% 
glycine. When the cell wall is weakened by glycine, high concentration of sucrose protects 
the cells from lysis by stabilising the osmotic pressure. The cells were grown at 30 °C for 
4-6 h until OD600 reached about 0.5. Culture was cooled down on ice before centrifugation 
(7000 rpm, 7 min, 4 °C) for collecting cells. Cells were washed twice with ice-cold 
electroporation buffer and resuspended in 1 ml buffer, and frozen in 100 µl aliquots. For 
electroporation, 100 µl competent cells were mixed with maximum 10 µl DNA samples in 
electroporation cuvette (gap 2 mm). Electric pulse was generated at 2 kV, 25 µFD and 400 
Ω resulting in time constants about 7.5-8.5 ms. Cells were incubated in 1 ml of recovery 
media at 30 °C for 1 h. The cells were plated on M17G agar with Nis
50
. Plates were 
incubated at 30 °C for 1-2 d.  
 
4.4.2 L. monocytogenes transformation 
 
L. monocytogenes was grown overnight in BHI broth at 30 °C with shaking. To prepare 
competent Listeria cells, 500 µl of the o/n culture was inoculated in 10 ml BHI 
supplemented with 0.5 M sucrose. The cells were incubated at 30 °C with shaking for 2-3 
h until OD600 reached about 0.2. Then, 10 µg/ml penicillin G was added into the culture 
and the cells were grown for 2 h. Cells were cooled down on ice and collected by 
centrifugation (7000 rpm, 5 min, 4 °C). Cells were washed 3 times with ice-cold 
electroporation buffer and resuspended in 80 µl of the same buffer. For electroporation, 
competent cells were kept on ice (< 1 min) and mixed with maximum 10 µl DNA samples 
in electroporation cuvette (gap 2 mm). Electric pulse was generated at 2.2 kV, 25 µFD and 
200 Ω resulting in time constants about 4.2-4.8 ms. Cells were regenerated in 1 ml of 
recovery media at 30 °C for 2 h with shaking. The cells were plated on BHI agar with 
erythromycin. Plates were incubated at 30 °C for 2-3 d.  
 
4.4.3 E. coli transformation 
 
E. coli was grown overnight in LB broth at 37 °C with shaking. From the o/n culture, 2 ml 
was inoculated in 200 ml fresh LB. The culture was incubated at 37 °C with shaking for 2-
3 h until OD600 reached about 0.5. The cells were cooled down on ice and collected by 
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centrifugation (7000 rpm, 5 min, 4 °C). Cells were washed 3 times with ice-cold 10% 
glycerol. After washing, the cells were resuspended in 2 ml of 10% glycerol, and frozen in 
50 µl aliquots. For electroporation, 50 µl competent E. coli cells were mixed with 
maximum 5 µl DNA samples in electroporation cuvette (gap 2 mm). Electric pulse was 
generated at 2.5 kV, 25 µFD and 200 Ω resulting in time constants about 4.2-4.8 ms. Cells 
were incubated in 1 ml of recovery media SOC at 37 °C with shaking for 1 h. The cells 
were plated on LB agar with erythromycin. Plates were incubated at 37 °C for o/n.  
 
4.5 Southern blot 
 
DNA was transferred from gel to nylon membrane by vacuum blotting (LKB Bromma 
2016 VacuGene Vacuum Blotting Pump). DNA on membrane was hybridised and detected 
according to Boehringer-Mannheim (Germany) non-radioactive digoxigenin (DIG) 
labelling kit (DNA Labeling and Detection Kit). DNA probes used in this study were made 
by PCR, in which DIG-labelled dUTP is randomly incorporated with Taq polymerase. In 
Southern blot, DNA was separated in agarose gel, denaturated in gel, and transferred to 
nylon membrane (Southern 1975). During o/n incubation at 68 °C, DIG-labelled DNA 
probes specifically hybridise with the complementary, single stranded DNA fragment(s) on 
the membrane. In immunological detection, the alkaline-phosphatase-conjugated DIG 
antibody binds to DIG-labelled probes. Then, the membrane is covered with NBT/X-
phosphate solution. The phosphatase attached to the antibody degrades the substrate X-
phosphate, resulting in the formation of the insoluble NBT diformazan with purple colour 
on the membrane. Buffers and solutions used in Southern blot and detection are listed in 
Appendix 5.  
 
4.6 Leucocin C antilisterial activity bioassay 
 
LecC antilisterial activity was determined by conventional spot-on-lawn method. The 
indicator strain L. monocytogenes WSLC 1018 was grown in BHI media for o/n. 200 µl of 
the cell culture was added to 5 ml of melted (about 50 °C) BHI soft agar, thoroughly mixed, 
and poured onto the top of BHI agar plate. A 5 µl droplet of either cell suspension or 
pasteurised culture supernatant (75 °C, 10 min) was spotted onto the surface of the BHI 
soft agar. The zone of inhibition was observed on Listeria plate after o/n incubation at 
30 °C. 
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4.7 Leucocin C immunity assay 
 
To determine Listeria sensitivity to LecC, 3 µl of o/n cultures were added to 300 µl BHI 
Erm
5
 containing Lc. lactis LecC supernatant with different concentrations (0-100 µl/ml) in 
Bioscreen microtiter plates (100 wells). The plates were grown in Bioscreen C 
(Labsystems, Helsinki, Finland) at 30 °C with constant shaking for 24 h. The optical 
density was measured at 600 nm wavelength in every 2 h. 
 
4.8 Primers and sequencing 
 
PCR products and plasmid constructs were sequenced by out-sourced DNA sequencing 
service (Institute of Biotechnology, University of Helsinki). Primers used in this study are 
listed in Table 6. Primers were synthesised by Oligomer Oy (Helsinki, Finland), except 
lecC forward and reverse primers, pepR and leuAI primers, which were synthesised before 
this study. In order to obtain complete sequence of large unknown DNA fragments, primer 
walking method was used, which included serial sequencing, designing and synthesising 
new primers (Figure 9, p52). 
 
Table 6. Primers used in this study. Relevant restriction sites added to the primers are underlined. 
Primer Use, restriction site Sequence 5’  3’ 
lecC forw lecC AAAAACTACGGTAACGGTGTTCACTG 
lecC rev lecC, 1600 bp, 2500 bp ACTGCATGCTTACTTGTGCCAACCAGCGTTACC 
lecC new rev lecC TTAGTTATGCCATCCAGCATTGC 
lecC inverse forw inverse PCR GTTATGAATGGCCTAACCGGC 
lecC inverse rev inverse PCR GTTTGCGATGTTGGTCCACGC 
lecI forw lecI, BspHI ACTTCATGAAAATAAGATGGTTTTCTGGTG 
lecI rev lecI, lecI probe TCAGTAGCCATATCTAATACTAGA 
lecI ApoI forw lecI probe TCTGCTGTTCCCCTTATAGATG 
leuAI forw leuAI AAGTATTATGGTAACGAGTTC 
leuAI rev leuAI ACTGAATTCGCGGCCGCTATCTTTCAAAGATACTATAAAAC 
PpepR forw PpepR, EcoRI ATGTGGAATTCTGCTTTGATACTCACCA 
PpepR rev PpepR AGCCGGATCCTTAGGTCAGGATCGTTGTTC 
Trans rev 1600 bp, 2500 bp GTTGATTTCCCAGAACCACT 
lecC upstr seq primer walking ATAGCCCCAATCAACTGAGC 
Trans seq1 primer walking GACATGGAAGGAACGACTGC 
Trans seq2 primer walking GCGTTGAGACGATTAAAGCG 
Trans seq3 primer walking CCCAATAGCTCATTAGTAGC 
Trans seq4 primer walking CCAACTCTGATTATTGTGCC 
Trans seq5 primer walking CTAAAGGCACAACCATTGCG 
repA downstr forw vector primer TTATTTTGGTTTGATGTTGCGAT 
Erm rev vector primer TTATAGTTTTGGTCGTAGAGC 
 
 
 
 
46 
 
4.9 Data analyses 
 
Primers were designed manually according to the existing and/or obtained sequences. 
Oligo analyzer (http://eu.idtdna.com/analyzer/applications/oligoanalyzer/) was used to 
analyse designed PCR primers and to determine the melting temperatures for PCR or 
sequencing.  
 
The search for homology of DNA and amino acid sequences was performed with BLAST 
(blastn and blastp, http://blast.ncbi.nlm.nih.gov/Blast.cgi). Another online tool, ClustalW2 
(http://www.ebi.ac.uk/Tools/msa/clustalw2/), along with BLAST, was also used to 
generate sequence alignments for DNA or proteins for sequence comparison.  
 
NEBcutter V2.0, an online programme available to the public 
(http://tools.neb.com/NEBcutter2/), was used to determine the cleavage sites of DNA with 
restriction enzymes. 
 
A translate tool in ExPASy (SIB Bioinformatics resource portal, 
http://web.expasy.org/translate/) was introduced to predict possible ORFs and to translate 
nucleotide DNA sequences to protein sequences. 
 
5 RESULTS 
 
5.1 Localisation of leucocin A and C genes 
 
As most class IIa bacteriocin genes are plasmid-associated, the first aim in this study was 
to find out the loci of the genes needed for LeuA and LecC production in Ln. carnosum 
4010 genome with leuA and lecC gene probes by Southern blot. The probes were produced 
and labelled by PCR. The leuA gene was amplified with its immunity gene (leuAI) with 
PCR primers designed according to previously published gene sequences. Because of the 
unknown nucleotide sequence of lecC, the PCR primers for amplifying the lecC gene were 
designed according to LecC amino acid sequence. The amplicons were confirmed to be 
leuA and lecC by sequencing (Takala, unpublished result).  
 
The Ln. carnosum 4010 plasmid DNA was isolated, separated in gel electrophoresis, 
transferred to nylon membrane and hybridised with DIG-labelled leuA and lecC DNA 
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probes. Ln. carnosum 4010 was found to carry several plasmids (Figure 4 (a)). In the 
Anderson and McKay plasmid isolation method, some chromosomal DNA is also obtained 
resulting in an extra band of about 14 kb. Two plasmid bands were below the chromosomal 
band, and two plasmid bands above. It is not known whether those bands are all different 
plasmids or same plasmids of different supercoiling degrees. However, as the smallest and 
the largest bands migrated very differently in gel, at least these two bands should represent 
different plasmids. The lecC probe hybridised with two bands, the largest plasmid band 
and the chromosomal band, while leuA probe hybridised with other plasmid bands (Figure 
4 (b)). Coincidentally, the leuA positive control plasmid pTMT46 produced bands with 
nearly the same size as those from the native leuA plasmid of 4010. During plasmid 
isolation, large plasmids might undergo partial degradation, which resulted in the 
migration of plasmid fragments along with the chromosomal band in agarose gel. 
Therefore, the lecC signal observed from the chromosomal band was presumably due to 
the presence of broken plasmids. In conclusion, the genes for the productions of the two 
bacteriocins were shown to be both plasmid-associated but located in different plasmids of 
Ln. carnosum 4010. 
 
Figure 4. Agarose gel electrophoresis of Ln. carnosum 4010 total DNA and Southern blot membranes 
hybridised with lecC (a) or leuA (b) probes. Chr, chromosomal band. pTMT46, previously constructed 
plasmid carrying leuA, about 8 kb. pTF1, negative control plasmid. Marker, GeneRuler™ 1 kb DNA ladder 
(Fermentas). 
 
5.2 Characterisation of leucocin C operons 
 
Since lecC gene was shown to be located in a different plasmid than the one carrying leuA, 
it seemed that the two bacteriocins would have independent systems for their productions, 
and the large plasmid probably would also carry other LecC related genes. Therefore, the 
next aim was to identify the possible genes needed for LecC production by sequencing the 
flanking regions of lecC. Different approaches, including iPCR and restriction-Southern 
strategy, were used to obtain lecC-flanking fragments for sequencing. As both upstream 
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and downstream regions of lecC were searched simultaneously, and as it is more 
convenient to present them separately, the following paragraphs are not in an entirely 
chronological order. 
 
5.2.1 The immunity gene 
 
The immunity gene of a class IIa bacteriocin is usually found in the same operon 
downstream of the corresponding bacteriocin gene. In the subclassification of immunity 
proteins for class IIa bacteriocins, subgroup B immunity proteins share a C-terminal 
conserved motif (SNIRYGY) (Figure 5). The corresponding bacteriocins for all of these 
structurally similar immunity proteins belong to the subgroup 1 (Table 2, p19 and Figure 
5). Since LeuC is also considered to belong to subgroup 1, its immunity protein is likely to 
contain the same C-terminal motif (SNIRYGY). Therefore, a consensus PCR primer (lecI 
reverse) was designed according to gene sequences of the conserved C-terminal regions of 
subgroup B immunity proteins and used in PCR with the lecC forward primer in order to 
obtain the fragment containing lecC and its putative immunity gene.  
 
The amplicon with the size of 432 bp was obtained and confirmed to contain lecC and a 
novel ORF by sequencing. Between 132 bp lecC and the new 294 bp gene there were six 
non-coding bases (Figure 6). The mature lecC and its downstream ORF, named lecI in this 
study, were found to be unique genes. The nucleotide sequences of lecC and lecI shared no 
significant sequence similarity with any known genes in GenBank. However, the protein 
encoded by lecI was homologous with several class IIa immunity proteins, with the best 
matches to listeriocin 743A and sakacin P immunity proteins (48% identity, 73% similarity) 
(Figure 5).  Though, no homology was found between LecC and LeuA immunity proteins. 
 
Figure 5. Sequence alignment of leucocin C immunity protein and its similar immunity proteins of other 
class IIa bacteriocins. The immunity proteins for the following class IIa bacteriocins belong to subgroup B: 
leucocin C (LecC-im), listeriocin 743A (LisA-im), sakacin P (SakP-im), piscicolin 126 (Pisc-im), mundticin 
KS (MunKS-im) and enterocin CRL35 (EntCL-im). Black, grey and light grey boxes indicate regions of 
sequence similarity. Except LecC-im, the figure was adapted from Fimland et al. (2005). 
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Figure 6. Nucleotide sequence of the lecCI operon and their flanking regions. Restriction sites are in bold 
and italic with different highlight colours: relevant ApoI light green, other ApoI sites bold and italic, HpaI 
light red, AclI light blue. Sequence in purple refers to the accessory gene nearly identical with that of 
leucocin A. PCR primers are underlined: inverse primers in lecC gene, lecI Apo forward primer in lecI gene. 
Terminator of lecCI operon is underlined and palindromic sequences are highlighted with yellow. 
 
5.2.2 The downstream of lecI 
 
As the gene sequences of lecI only confirmed the existence of LecC immunity gene, the 
actual 3‟-end of lecI and its downstream sequence still remained unknown. Thus, in order 
to identify the downstream sequence of lecI, restriction-Southern method was used. The 
lecI probe for Southern blot was produced and labelled by PCR. The Ln. carnosum 4010 
plasmid DNA was digested with ApoI, separated in gel, transferred to nylon membrane, 
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and hybridised with lecI probe. The lecI gene was cloned into pLEB688 and used as the 
positive control (detailed information in chapter 5.3, p52). 
 
The quality of plasmid DNA preparation was good enough to get clear bands after ApoI 
restriction (Figure 7 (a)). Two bands with approximate size of 400 bp and 300 bp were 
detected on nylon membrane (Figure 7 (b)). Detected fragments were extracted from gel, 
and ligated with pTF1 (EcoRI, compatible with ApoI). Using lecI ApoI forward and vector 
Erm reverse primers and the ligation mixture (400 bp Apo+pTF1) as template, fragments 
with the size of about 500 bp, 600 bp and 1 kb were amplified by PCR (Figure 7 (c)). As 
the expected size of amplicons from lecI ApoI forward primer and the vector primer was 
about 570 bp, the 600 bp band should carry the right insert, and the other two bands might 
come from unspecific binding of primers. The 600 bp fragment was then extracted from 
gel and sequenced. A 392 bp fragment comprised by lecI and its downstream sequence 
(136 bp) was identified. However, the existence of a transcriptional terminator or a new 
ORF was not found (Figure 6, p49). 
 
 
Figure 7. Agarose gel electrophoresis of Ln. carnosum 4010 total DNA restricted with ApoI, plasmid 
pLEB730 carrying cloned lecI, empty vector pTF1 (a) and its corresponding hybridised membrane with lecI 
probe after Southern blot (b); agarose gel of PCR amplicons from ligation mixture (400 bp Apo+pTF1) with 
lecI ApoI forward (forw) and Erm reverse (rev) primers (c). Markers in (a, b), GeneRuler™ 1 kb DNA ladder 
(Fermentas). Marker in (c), GeneRuler™ 50 bp DNA ladder (Fermentas). 
 
To acquire more genetic information of the downstream region of lecI, the Ln. carnosum 
genomic DNA was restricted with HpaI, self-ligated and used as the template in iPCR. A 1 
kb band containing lecCI and its downstream sequence was obtained by iPCR and 
confirmed by sequencing with lecI ApoI forward primer. From 178 bp downstream from 
the stop codon of lecI, there started a nearly perfect palindromic sequence, which might 
function as a Rho-independent transcription terminator (Figure 6, p49). 
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5.2.3 The upstream of lecC 
 
The presence of the lecCI terminator indicated the end of the operon. However, the start 
point, namely the upstream region of this operon remained unknown. Ln. carnosum 4010 
plasmid DNA restricted by ApoI was self-ligated and used as the template in iPCR. A 
segment with the size of about 600 bp was amplified. This fragment harbouring lecC and 
its upstream region was confirmed by sequencing. The upstream region of lecC was found 
to be 99% identical to that of leuA operon from Ln. gelidum, and seemed to contain a gene 
encoding accessory protein for bacteriocin secretion (Figure 6, p49). In the sequence, a 72 
bp signal sequence encoding a GG-type leader was identified. The SSlecC was different 
from the SSleuA in Ln. gelidium UAL187 by 5 nt, whereas the leader peptide differed by 
only 1 aa residue (Figure 8).  
 
 
Figure 8. Sequence comparison between the signal peptides of leucocin A and leucocin C. Grey boxes 
indicate the difference.  
 
5.2.4 The transporters 
 
As there seemed to be an accessory gene for ABC transporter in the lecC upstream 
sequence, LecC is most likely secreted via the same kind of transporter as other class IIa 
bacteriocins. Thus, the next task of genetic characterisation was to identify the transporter 
genes for LecC secretion. For that, like designing lecI reverse primer, transporter 
sequences of several class IIa bacteriocins were compared and a conserved region was 
found in the middle of the translocator gene (Figure 9 and Appendix 6). Then, a consensus 
primer (Trans reverse) was designed and used in PCR with lecC reverse primer. Two 
bands (2500 bp and 1600 bp) were amplified, both of which were shown to carry lecC by 
sequencing. However, the obtained sequences were short, probably because of the quality 
of sequencing templates. Only 183 bp was sequenced from the lecC and its upstream 
region, but no further sequence was identified (results not shown). 
 
The next attempt was to amplify lecC upstream fragments by iPCR. Ln. carnosum plasmid 
DNA was cut by AclI, self-ligated and subject to PCR with inverse primers. A large 
fragment (~8 kb) was amplified and sequenced by primer walking strategy (Figure 9). The 
fragment was found to carry another operon in the opposite direction to lecCI. The operon 
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was comprised of two genes (secretion gene lecS and translocator gene lecT) for ABC 
transporter, and an accessory gene (lecX). Interestingly, the accessory gene and the 
transporter genes were practically identical with those of leuA operon (97% identity) in Ln. 
gelidum UAL187. The 8 kb fragment was entirely sequenced, but no other lecC-related 
genes/ORFs were found. The sequence of the 4920 bp LecC gene cluster is in Appendix 6. 
  
In conclusion, the genes required for the production of LecC were characterised (Figure 9). 
Five genes required for LecC production were identified: the structural gene (lecC), the 
immunity gene (lecI), a gene (lecX) for an accessory protein and two genes (lecTS) for an 
ABC transporter. The structures of the two lecC operons were actually the same as leuA 
operons in Ln. gelidum. The five genes in two operons were identified to be class IIa 
associated genes by sequence homologies. The lecXTS genes and lecC secretion signal 
sequence were found highly identical to those of leuA, while the lecCI were novel. The 
novel gene lecI encodes a putative immunity protein for LecC, but experimental evidence 
would be needed to confirm its function. 
 
 
Figure 9. Organisation of the genes needed for the production of leucocin C and the loci of primers for 
primer walking. trsR, Trans reverse primer. Promoters are shown as black flags. Transcriptional terminators 
are shown as lollipop symbols.  
 
5.3 Heterologous expression of leucocin C 
 
In order to study the function of LecI, the bacteriocin LecC would be needed. As the wild-
type Ln. carnosum 4010 also produces LeuA, which kills Listeria as well, the LecC 
peptide should be purified from the culture supernatant. Therefore, an easier way to get 
pure LecC would be to produce the bacteriocin in a heterologous non-bacteriocinogenic 
host, for example Lc. lactis. The mature lecC gene with and without the immunity gene 
lecI was amplified by PCR and cloned into the plasmid pLEB690 at NaeI site (Figure 10-I). 
Cloning at NaeI site allowed blunt-end fusion with the SSusp45 in pLEB690 and the 
cloned lecC with no extra N-terminal aa residues in the mature secreted bacteriocin. The 
lecI gene (BspHI, compatible with NcoI) was also cloned alone into pLEB688 (NcoI, SmaI) 
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as a control (Figure 10-II). Adding NcoI in the lecI forward primer would have changed the 
second aa in LecI from Lys to Glu, therefore BspHI was used. 
 
 
Figure 10. Construction of plasmids derived from the food-grade vector pLEB690 (I) and plasmid pLEB730 
carrying lecI gene (II). pLEB690 was derived from pLEB688 with the insertion of nisin inducible promotor 
PnisZ and the lactococcal SSusp45 (Li et al. 2011). The vector plasmid pLEB690 (Ia) was restricted with NaeI 
and ligated with PCR fragments of lecC (Ib) or lecCI (Ic) without lecC signal sequence. The vector pLEB688 
was digested with NcoI and SmaI, and ligated with the PCR fragment of lecI digested with BspHI (II).nsr, 
nisin resistance gene. P45, constitutive lactococcal promoter. 
 
The constructed plasmids were introduced into Lc. lactis MG1363 for constitutive 
expression and into NZ9000 for nisin-inducible expression. The production of LecC was 
determined by spot-on-a-lawn antilisterial assay. Functional LecC was efficiently secreted 
by Lc. lactis strains. However, the co-expressed lecI did not improve the production 
(Figure 11). Previously papA encoding mature pediocin was cloned into the same plasmid 
in the same way (Li et al. 2011). In this study, that plasmid was used to compare the 
production and antilisterial activity of pediocin and LecC. Interestingly, even though 
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pediocin and LecC belong to the same subgroup (subgroup 1) of class IIa bacteriocins, Lc. 
lactis was capable to produce LecC far more effectively than pediocin with or without the 
immunity protein. Moreover, nisin induction could improve the production of pediocin to 
some extent, whereas the expression level of LecC was highly increased by nisin induction. 
Hence, LecC producing Lc. lactis could be used as LecC source for the following study on 
the function of the putative immunity gene lecI. 
 
 
Figure 11. Antilisterial bioassay of Lc. lactis expressing lecC, lecCI, papA (pediocin) or lecI, compared to 
the wild-type bacteriocin producers Ln. carnosum 4010 (LecC) and Lb. plantarum WHE 92 (pediocin). Onto 
Listeria lawn, 5 μl of cell suspension (left) and corresponding supernatants (right) were spotted. All host 
strains were cultured with nisin (0.5 µg/ml) as selective agent for the plasmids and/or for nisin induction. 
Second row from top, Lc. lactis MG1363 as the host strain. Third row from top, nisin-inducible Lc. lactis 
NZ9000 as host. V, the vector plasmid pLEB690. 
 
5.4 Demonstration of the immunity function of LecI 
 
The last aim of this study was to confirm whether the putative immunity gene lecI really 
conferred the immunity to LecC. Since the previously constructed lactococcal lecI-plasmid 
pLEB730 is not selectable in Listeria, the lecI gene was cloned under the control of the 
lactobacillar pepR promoter into pTF1 (Figure 12).  
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Figure 12. Construction of plasmid pLEB732 for expression of lecI in Listeria. The pepR promoter and lecI-
containing plasmid pLEB730 were restricted with BclI and BglII, respectively. PCR fragment containing 
PpepR and lecI was digested with EcoRI and inserted into the shuttle vector pTF1 (EcoRI, SmaI). 
 
Ligated pTF1-lecI was first transferred into E. coli TG1 resulting in the plasmid pLEB732. 
The constructed plasmid pLEB732 and the vector pTF1 were then electroporated into L. 
monocytogenes WSLC 1018. Subsequently, the Listeria transformants were grown with 
serial concentrations of LecC-producing Lc. lactis supernatant. The growth was monitored 
with Bioscreen C plate reader. The growth curves are shown in Figure 13. The vector and 
LecI strains grew equally in LecC-free media. The growth of both strains was retarded 
when LecC supernatant was added, but the retardation degree of the vector strain was 
considerably higher than the LecI-producing strain (Figure 13). In media with higher LecC 
concentrations, the difference in growth between the two strains was less pronounced (data 
not shown), showing that the immunity capacity of LecI was limited. Nevertheless, 
production of LecI did protect Listeria cells against LecC, corroborating the immunity 
function of lecI gene. 
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Figure 13. Growth of LecI-producing Listeria in different LecC concentrations (0, 5, 10 µl of LecC-
producing Lc. lactis supernatant/ml). Vector, Listeria carrying pTF1.  
 
6 DISCUSSION 
 
Bacteriocins of LAB have been studied, characterised, and classified into three classes. 
The unmodified class IIa bacteriocins are characterised by their antilisterial activity. Ln. 
carnosum 4010 as a protective culture in meat products has been shown to produce two 
class IIa bacteriocins, LeuA and LecC (Budde et al. 2003). LeuA has been well studied and 
all the genes needed for its production are known, whereas the knowledge of LecC had 
been fairly limited. Its amino acid sequence has been revealed, and it is known to kill 
pathogenic Listeria. In this study, the genes involved in the production of LecC were 
identified and characterised. In addition, bioactive LecC was efficiently produced by the 
heterologous host Lc. lactis.  
 
Previously, the LecC as a secreted peptide from Ln. mesenteroides 6 was purified and the 
amino acid sequence of mature LecC was determined (Fimland et al. 2002b). Nevertheless, 
the identity and location of LecC related genes were not known. Most class IIa bacteriocins 
are encoded by plasmid-associated genes (Ennahar et al. 2000). A few exceptions are 
enterocin A (Aymerich et al. 1996), divercin V41 (Metivier et al. 1998), sakacin P (Huhne 
et al. 1996), and carnobacteriocin B2 and BM1 (Quadri et al. 1997b). Genes needed for the 
productions of those bacteriocins are localised on the bacterial chromosomes. The results 
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in this study showed that like most class IIa bacteriocins, LecC genes were also plasmid-
associated, and the genetic determinants of LecC co-resided in an individual plasmid in Ln. 
carnosum 4010. Since there have not been other genetic studies on LecC, it cannot be 
excluded that in some other LecC producing strains the bacteriocin associated genes could 
be on the bacterial chromosomes. 
 
In this study, two LecC operons containing five genes were characterised. Recently, LecC 
was classified into the subgroup 1 of class IIa bacteriocins along with other closely related 
bacteriocins, such as sakacin P, listeriocin 743A, and enterocin CRL35, which share high 
sequence similarity with LecC (Nissen-Meyer et al. 2009). According to the same 
subclassification scheme, LeuA belonged to the subgroup 2. However, the organisations of 
the genes involved in the production of class IIa subgroup 1 bacteriocins are diverse 
(Figure 14). Pediocin genes were all found in a single operon, with the secretion genes 
(papCD) following the structural and immunity gene (papAB) (Marugg et al. 1992; Miller 
et al. 2005). In most cases, for example LeuA and sakacin P, the bacteriocin structural 
genes are followed by its cognate immunity gene in the same operon, and another operon(s) 
contains genes for secretion proteins. The organisation of lecCI operon in Ln. carnosum 
4010 agreed with previous findings, i.e., the immunity gene lecI was found immediately 
downstream of the structural gene lecC. Interestingly, the organisations of LeuA and LecC 
operons were the same. Moreover, the lecXTS genes encoding an accessory protein, 
translocator and secretion protein for LecC were nearly identical to those of LeuA (van 
Belkum and Stiles 1995). Although LecC shares high sequence similarity and belongs to 
the same subgroup with listeriocin 734A and sakacin P, the organisations of these 
bacteriocins‟ operons are different (Figure 14). Unlike listeriocin 734A, which does not 
possess own transporter genes and is secreted by the sec-pathway, LecC is secreted by its 
cognate ABC-transporter system encoded by lecXTS. Besides, in the case of sakacin P, two 
genes sppK and sppR encode the histidine protein kinase and the response regulator of a 
2CS (Tichaczek et al. 1994), while in this study, regulatory genes were not found in the 
lecC flanking regions. On the other hand, divercin V41 regulatory genes are located 910 nt 
downstream from its immunity gene, though they share the same operon (Metivier et al. 
1998). Since only 410 nt after the lecCI operon was sequenced in this study, it is not 
impossible that LecC biosynthesis is regulated and these regulatory genes locate in the 
same plasmid further downstream of lecI or at other genetic loci.  
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Figure 14. Organisations of the genes for the production of some class IIa bacteriocins. Genes encoding 
following proteins with shading patterns: bacteriocin (red), immunity protein (green), ATP-dependent 
translocator (blue), accessory protein (light blue), secretion protein (dark blue), histidine protein kinase 
(orange), respose regulator (yellow), undefined orf (white). Promoters (black flag), terminators (lollipop 
symbol). Sequence for divercin V41 is not complete; here is its putative schematic organisation. 
 
In order to secrete antilisterial bacteriocins in Lc. lactis strains, the usp45 lactococcal 
secretion signal has been used to replace the original signal sequences of these bacteriocins 
(Borrero et al. 2011; Li et al. 2011). In previous study, mature enterocin P gene was fused 
with SSusp45 into a lactococcal expression vector. The constructed plasmid was 
transferred into Lc. lactis strain resulting in heterologous production of bioactive enterocin 
P against L. monocytogenes 4032 and E. faecium T136 (Borrero et al. 2011). Similar 
principle was applied for producing pediocin by Lc. lactis using a food-grade secretion 
vector with nisin selection (Li et al. 2011). The papA gene encoding mature pediocin was 
fused to usp45 signal sequence carried by the food-grade vector pLEB690. As a result, 
pediocin secreted by Lc. lactis host strain killed Listeria. Here, in our study, production of 
LecC in Lc. lactis confirmed the applicability of SSusp45 and pLEB690 in secreting other 
class IIa bacteriocin than pediocin. Surprisingly, LecC-producing Lc. lactis strains killed 
Listeria better than pediocin producer constructed by Li et al.(2011). With nisin induction, 
the difference between the inhibitions of Listeria by the two bacteriocins was even more 
pronounced (Figure 11, p54). As the yields of bacteriocins expressed by host strains were 
not determined in this study, it remains possible that the indicator strain L. monocytogenes 
WSLC 1018 is more sensitive to LecC than to pediocin. However, it is more likely that for 
some reason Lc. lactis could produce LecC more efficiently than pediocin. Previously, co-
expression of pediocin immunity gene was shown to increase the yields of pediocin by host 
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Lc. lactis (Arques et al. 2008). Yet, there was no significant improvement in the production 
of LecC by the co-expression of lecI (Figure 11, p45). Although Lc. lactis is resistant to 
both LecC and pediocin, the strain seems to be somewhat sensitive to pediocin, and 
therefore the expression of LecC was more efficient.  
 
Even though it seems that LecI helped to produce more LecC, the production of LecC was 
actually not limited due to the immunity problem, because with nisin induction 
Lactococcus was able to produce even more bacteriocins. The results indicated that the 
production of LecC by Lc. lactis MG1363 was constrained not because of the absence of 
its immunity protein but mainly because of the strength of the promoter. Nisin promoter is 
known to be stronger than the P45 promoter (Li et al. 2011). That explains why the 
production of LecC under nisin promoter was more effective than that under the P45 
promoter (Figure 11, p54).  
 
Earlier, nisin-induction in Lc. lactis NZ9000 increased the production of pediocin by the 
host (Li et al. 2011). In our study, nisin-induced LecC production was even more 
prominent increasing Listeria inhibition up to the wild-type level (Figure 11, p54). Though, 
it is not known how much exactly Ln. carnosum 4010 produces LecC, because the strain 
also produces LeuA, which is active against Listeria (Budde et al. 2003). Therefore, since 
the inhibition zones were about the same in size, the heterologous host Lc. lactis probably 
produced more LecC than the native producer strain. In conclusion, this study shows that 
Lc. lactis as a heterologous host is able to produce large amount of class IIa bacteriocin for 
potential use in food industry.  
 
A common approach to demonstrate the function of an immunity protein is to express the 
putative im-gene in a bacteriocin-sensitive host, and to examine the increase of bacteriocin 
resistance. Previously, the functions of bacteriocin immunity genes of e.g., enterocin A, 
LeuA, sakacin P, and carnobacteriocin B2 have been shown by expressing them in 
heterologous hosts (Axelsson and Holck 1995; Huhne et al. 1996; Quadri et al. 1997b; 
Fimland et al. 2002a). The gene lecI identified in this study was shown to confer immunity 
by expressing lecI in LecC sensitive Listeria (Figure 13, p56). The sensitivity of LecI-
producing Listeria towards LecC decreased, and this strain could grow in LecC containing 
medium. It is worth noticing that this study presents the first expression of an immunity 
gene in Listeria.  
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As the class IIa immunity proteins share some similarity in their amino acid sequence, it is 
possible to identify several common motifs in sequence comparison (Fimland et al. 2002a). 
Based on these common motifs, three subgroups have been suggested. In the subgroup B, 
all class IIa bacteriocin immunity proteins and two orphan immunity proteins (orfβ3-im 
and orf285-im) contain a C-terminal consensus motif (SN/SIRYGY) (Fimland et al. 2005; 
Drider et al. 2006). The amino acid sequence of LecI has the SSIRYGY region in its C-
terminus, showing LecI homology with immunity proteins in this class (Figure 5, p48). 
Therefore, LecI is now suggested to be included in subgroup B immunity proteins of class 
IIa bacteriocins. Interestingly, bacteriocins pediocin and LecC are sorted in the same class 
IIa subgroup 1 (Nissen-Meyer et al. 2009), but their associated immunity proteins are quite 
different and belong to different subgroups (pediocin-im in subgroup A). However, even 
though they are so different, pediocin-im protects the host against LecC (Fimland et al. 
2002a). 
 
Earlier, the amino acid sequence of LecC was published, yet the sequence only covered the 
section of mature peptide (Fimland et al. 2002b). As revealed in this study, the DNA 
sequence of lecC gene also contains a conserved signal sequence region encoding a 
polypeptide with two consecutive glycine codons in its terminus, the GG-type leader 
peptide. The GG-leader is known to be cleaved off during the transportation of mature 
peptide to the outside of the producer cells. Though, secreted LecC and LeuA are different, 
homology comparisons of the GG-type leader with that of LeuA precursor showed high 
similarity between the two, with only one amino acid difference (Figure 8, p51). A GG-
type leader is associated with the function of ATP-binding cassette (ABC) transporter for 
secretion of the peptide (Nissen-Meyer et al. 2009). Because of the high identity of 
transporter genes lecXTS with LeuA transporters (lcaECD) and also mesCDE for the 
secretion of mesentericin Y105 in Ln. mesenteroides FR52 (van Belkum and Stiles 1995; 
Aucher et al. 2004), it seems that these bacteriocins are secreted via similar transporters. 
Recently, in Ln. carnosum 4010, LeuA transporter accessory gene was recently shown to 
be interrupted with a putative transposase, therefore there is no LeuA dedicated transporter 
in this strain (Takala, unpublished). Thus, in this strain LeuA might be exported either by 
LecC secretion system or by other ABC-type pathways.  Several Leuconostoc strains have 
been reported to produce both LeuA and LecC (Papathanasopoulos et al. 1998; Vaughan et 
al. 2001; Sawa et al. 2010). However, no one has showed the productions of these two 
bacteriocins would correlate with each other. It is still unknown whether LeuA and LecC 
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in the strain 4010 are secreted by the same system. Further studies on LeuA and LecC 
correlation would be required. 
 
7 CONCLUSIONS  
 
In this study, genes needed for the production of a class IIa bacteriocin LecC in Ln. 
carnosum 4010 were localised and characterised. The lecC gene encoding LecC precursor 
with a GG-type leader peptide was localised in a large plasmid of Ln. carnosum 4010. Five 
genes arranged in two opposite operons were identified for LecC production. One operon 
contains two novel genes with no matches to known genes in Genbank: the structural gene 
encoding LecC precursor and the immunity gene lecI. The other operon includes genes 
lecXTS encoding an accessory protein, an ATP-dependent translocator and a secretion 
protein, respectively. By exchanging lecC original signal sequence with a lactococcal 
signal sequence of usp45, bioactive LecC was efficiently produced by Lc. lactis. The 
immune function of the lecI gene was shown by expressing lecI in LecC sensitive Listeria. 
LecI-producing Listeria was less sensitive to LecC. 
 
The organisation of LecC operons was the same as that of LeuA in Ln. gelidum UAL187. 
The upstream region of LecC including the lecXTS genes and non-coding sequences was 
97% identical with known leuA (Ln. gelidum UAL187) sequences. The GG-type leader of 
LecC was different with LeuA leader only by 1 aa residue. Since in Ln. carnosum 4010 
there is no dedicated transporter for LeuA secretion, both LeuA and LecC in this strain 
could be secreted with LecC transporter. Therefore, it would be interesting to study the 
exportation of LeuA in this strain and/or parallel strains producing both leucocins and to 
demonstrate the in/dependency of bacteriocins produced by the same strain.  
 
Bioactive LecC was efficiently produced using the food-grade vector pLEB690 both 
constitutively and with nisin induction. The positive effects of nisin induction on the 
production of LecC overcame that of the immunity protein LecI. Lc. lactis could produce 
large amount of LecC, regardless of the presence of LecI. Thus, like in previous study (Li 
et al. 2011), the vector pLEB690 was shown to be a good tool for the production of 
functional bacteriocins in food industry.  
 
The food pathogen L. monocytogenes has not been used before as a heterologous host for 
the expression of a bacteriocin immunity gene. In this study, Listeria was able to 
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functionally express the lecI gene thus tolerating higher LecC concentration. The aim was 
not to create Listeria strain resistant to class IIa bacteriocin, but to demonstrate the 
function of the immunity protein. As the strain became less sensitive, lecI was confirmed 
to be the factor mediating the bacteriocin immunity. According to the sequence 
comparison, LecI was suggested to be a subgroup B immunity protein. 
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APPENDICES 
 
Appendix 1. Buffers used in Anderson & Mckay (1983) rapid plasmid isolation method. 
 
Name Ingredients  Concentration pH 
Buffer 1 Sucrose 
Tris-HCl 
EDTA 
6.7% 
50 mM 
1 mM 
8.0 
Buffer 2 Tris-HCl 25 mM 8.0 
Buffer 3 EDTA 
Tris-HCl 
250 mM 
50 mM 
8.0 
Buffer 4 SDS 
Tris-HCl 
EDTA 
20% 
50 mM 
20 mM 
8.0 
Buffer 5 Tris-HCl 2.0 M 7.0 
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Appendix 2. Enzymatic reactions and buffers. 
 
Restriction enzymes and their corresponding buffers 
Enzyme Restriction site 5' 
 3' 
Optimal buffer Optimal 
temperature 
Company 
FastDigest® 
AclI 
AA^CGTT 1 × FastDigest® 
Green Buffer 
37 °C Fermentas 
ApoI (XapI) R^AATTY* 1 × Tango 37 °C Fermentas 
BclI T^GATCA 1 × NEBuffer 3 50 °C New England Biolabs 
BglII A^GATCT 1 × NEBuffer 3 37 °C New England Biolabs 
BspHI T^CATGA 1 × NEBuffer 4 37 °C New England Biolabs 
EcoRI G^AATTC 1 × Buffer EcoRI 37 °C Fermentas 
HpaI GTT^AAC 1 × NEBuffer 4 37 °C New England Biolabs 
NaeI GCC^GGC 1 × Buffer A 37 °C Promega 
NcoI C^CATGG 1 × NEBuffer 3 37 °C New England Biolabs 
SmaI CCC^GGG 1 × NEBuffer 4 25 °C New England Biolabs 
* R = A or G, Y = C or T 
 
Recommended protocols for enzymatic reaction 
Enzymatic digestion 
H20 to 50 µl Incubate in supplied buffer at 
optimal temperature for 1-16 
hour 
10 × restriction buffer 5 µl 
DNA 1 µg 
Restriction enzyme 2 µl 
Total volume 50 µl 
Phosphorylation 
H20 to 50 µl Incubate at 37 °C for 30 minutes 
10 × T4 DNA ligase buffer 5 µl 
10 mM ATP 5 µl 
DNA 1 µg 
T4 PNK (10000 U/ml) 1 µl 
Total volume 50 µl 
Dephosphorylation 
H20 to 20 µl Incubate at 37 °C for 30 minutes 
DNA 1 µg 
10 × NEBuffer 3 2 µl 
CIP (10000 U/ml) 0.5 µl 
Total volume 20 µl 
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Appendix 3. PCR programmes. 
 
Enzyme Phusion HF polymerase Taq DNA polymerase 
Cycle step Cycles Temperature Time Temperature Time 
Initial denaturation 1 98 °C 1 min 30 s 94 °C 2 min 
Denaturation 
Annealing 
Extension 
30 98 °C 
x °C 
72 °C 
7 s 
20 s 
15-30 s/kb 
94 °C 
x °C 
72 °C 
30 s 
30 s 
1 min/kb 
Final extension 1 72 °C 5 min 72 °C 5 min 
Hold 1 4 °C hold 4 °C hold 
x optimal annealing temperature. As a basic rule, for primers > 20nt, anneal for 10–30 seconds at a Tm +3°C 
of the lower Tm primer. For primers ≤ 20nt, use an annealing temperature equal to the Tm of the lower Tm 
primer. 
 
 
 
 
 
 
 
 
 
 
Appendix 4.  Buffers and media used in electroporation  
 
Lc. lactis transformation 
Electroporation buffer 0.5 M sucrose 
15% glycerol 
Recovery medium 1 ml M17GS  
2 mM CaCl2 
20 mM MgCl2 
L. monocytogenes transformation 
Electroporation buffer 0.5 M sucrose 
1 mM Hepes 
Recovery medium 1 × BHI 
0.5 M sucrose 
E. coli transformation 
SOC 20 g/L BactoTM Tryptone 
5 g/L BactoTM Yeast Extract 
10 mM NaCl 
2.5 mM KCl 
10 mM MgCl2 
10 mM MgSO4 
20 mM glucose 
  
78 
 
Appendix 5. Southern blot solutions and buffers 
 
Name Ingredients  Concentration pH 
Preparation of Gel 
Depurination HCl 0.25 M - 
Denaturation NaOH 
NaCl 
0.4 N 
0.6 M 
- 
Neutralisation NaCl 
Tris-HCl 
1.5 M 
0.5 M 
7.5 
Transfer 
Transfer buffer, 10 × 
SSC 
NaCl 
Trisodium citrate 
1.5 M 
0.15 M 
7.0-7.2 
Hybridisation 
Hybridization buffer SSC 
Blocking reagent 
N-Lauroylsarcosine 
SDS 
5 × 
1% 
0.1% 
0.02% 
- 
Wash buffer 1 SSC 
SDS 
2 × 
0.1% 
- 
Wash buffer 2 SSC 
SDS 
1 × 
0.1% 
- 
Detection 
Buffer 1 Tris-HCl 
NaCl 
100 mM 
150 mM 
7.5 
Buffer 2 Blocking reagent 
Buffer 1 
1% 
1 × 
7.5 
Buffer 3 Tris-HCl 
NaCl 
MgCl2 
100 mM 
100 mM 
50 mM 
9.5 
Colour development 
buffer 
NBT 
X-phosphate 
Buffer 3 
4.5 µl/ml buffer 3 
3.5 µl/ml buffer 3 
1 × 
- 
TE buffer Tris-HCl 
EDTA 
10 mM 
1 mM 
8.0 
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Appendix 6. Gene sequence of leucocin C operons: lecXTS (complementary) and lecCI.  
 
lecS lecT lecX lecC lecI 
sequence primers terminator trans R primer inverse primer 
start codon stop codon aa different to that of leucocin A genes 
Restriction site    
 
AAACAGGTAAACACATTTTAAAATTATGTTTACCTGTTTAAATTAATTATTTTCACCTAAGACAATGTCCTTA
TAATAATTAAACCATGTTTTAGTGCCTTTAATGGTTGTGATGCGACCATTAAGACCATATTTAATCTGCTCGC
GTTCTGATTTGTTAGCCTGAATCGTCGCCACTAATTTATAAAAAGATCCCTCTTTACTGGCTATTGGTGCAGA
ACTAATACTTTTGATTGTTCCGTTTAAAGTCAGTGGCTTGGTAACATTTTGATTTGCGACAAAACGGATGGCT
TGTCTTTGCTTTAAGCCGATAATATTACTGGCAGGCACATAGTACTCAACATTCAAAGCTGTTTTTTGCGTCA
GTTTAGGATAAATTTGCGCAATGGTTGTGCCTTTAGGGAAATACTTGATTTTAGTTTTGTCAGTGGCTAAATG
TAAAATGCCATCTTCTGGTGCTTTAATAACCGTATCTTGATAATCCTCATTAGCAGAGGATTGCTTGGCTTTT
AACTCATCTAAGGATTGTTGCTGATCATTGATTTCTTTTTGAGCACTCGCTAGTTGTTGTTGCTTCAAGTCAG
CGATTTTATCTAAGGTACTGCTTTGAGATAAAGGACCACTCTTTGTAATACCAGCAATTTGACTATCATACGA
ACTACTCGTTGTTTGTAATTGATCAATTTGTTGTTGTACATTACTTAAGGCAGTTTGCTTGACTTGCTCTTTA
TCATCAGTTGTTTGTGCTGATTTTAACTGGGCTGCATAATTATCATAAATGGCCTGATAGGGATTATTAGTTG
GTTTAGTGTTGCTATTAATACTGGTTAGAATAGCTTGATAATTAGCTAATTGTTGATTATTTTTAGATTGGCC
TTGTTTTAAAACGTCAATTTGATGATTAGCTTGTTGATCAGCGGTTTGTTTATCACTACTTTGTTGATTAAAT
TCACTCATCAACGTATCAACTTGCGCCATATAGCCGTTGAATAGACTATCATAACCAAATTGATCTGTTCCAC
CAAATTCGCTACGTCCGTTAACAATACTCTGCTTATAGGTATCAAGACTTTTTAGACGGTCGTTAAGATTATT
AATTTGTTGCGTCAGTAATTGAGATGATATTTTTTCATTACCACTGGTAAAGGTCACTAATATATCGCCTTTT
TTAACCACTTTATTTTCAGTTAATTGGTTACTATCAATTGCGTTGTTACTCGTTGATTGGATATCTGATAGCA
CTTTGGCTGGAATAATTTCGCCACTTGCTTTGACAACAATTTCACGCTTAGCAAATAGGCTAAATAGAATGAT
AAACacGACTAACAAAAAAATAGGCACAATAATCAGAGTTGGAAAATTGCGGTAACGACGTTGATAAAATTCG
CCACTTTCTAAGTATTTTGGATCAAACATCAGGTCTCCTTAATGATTAAACAATGACGCGTAGAAACCACCGG
CATTAAGCAGAGTATTATGCGTGCCATCTTCGATAATTTTGCCGTTTTGCATGGTTAGAATACGATCTACTCG
CTGTGAAATGGTTAAGCGGTGCGCTACAAAGATAATGGTTTTTTCGGTTAACTGCATGAGATTATCAATAATC
TTTTTTTCTGTTAAAACATCAAGATTACTGGTTGACTCATCTAAAATCAGCACCGGAGAATCGACTAAAATGG
CTCTAGCTAAAGCAATGCGTTGTTTTTGACCACCCGAAATATTGCCACTTTCTGCGAGTTCAGTGCCAAATCC
TTGCGACATTTTTTCAATATCATCTTTAATTTCAGCAATTTCAACCGCCCTGATAATATCTTCTTGGGTTGTC
CCTGGCTTAGCCCCCAATAACAGGTTGTCCATAATTGAACCGGAAAATATAAAGGGTTCTTGTGGTAAATAAT
TAATGTGTGCTCTTAGCTCATGTTTATCAAGATTGGCGAGTGGTGTTTGTCCTAGTGAGATTGTTCCTGAATC
TGGTTGAAAGAAATTAACCAGCAATTTAACTAAAGTTGATTTACCTGATCCACTAATCCCAACCAAAGCGATT
TTTTCACCGGCTGTAATCGTTAGTGAAACATCATCAATTGCTGGCGCACCAAAACCGTATTTATAGGTGATAT
GATCCGCTACTAATGAGCTATTGGGCATAATGCTTTCTGTCATTTGATGACTAGCTTTAAATTCTGAATCAAC
CAAATAAACTTCGTTCAAACGATTATTAGCGACTGAGGCCTGTTGGAGCTTAGTTTGTAGATTAATAATATTT
TGCAAGGGATCTGTAAAAAATCCTAATAAAGCATTGTAAGTGATCAGTTGACCCACACTAATTTTATTGGTCA
TGACCAGTTGTGCGCCAACCCATAAGATCACGACATTTAAAGAGAGCTGTAAGAGGCTTTTAATCGCATTTTG
AGTGGCTTCTGTTTTAGCGTAAACAAATGATTTTTCTAAATAAGTGACAAATTCATGATCAATTTTATGATAG
GCGGTTTCTTCACTATTCAGCGCTTTAATCGTCTCAACGCCATTAATATCTTCAATAATGGAAGAACTTAACA
TCGAACCTGCTTGCATTTGGTCATTATTCATCTTTGAAAAAGGACGCATAAAGAGCCAGACCACTAGGGCATA
AGCCGGAATGGCAATCAGAGAAATCAGAAACAAGGTTGAATTTTGAACCACTAGCACTGTGCCAACAATGACC
AAAATTCCTAAGTCTAAAAATACAGATAACATCGTGCTTGCCAGGGCTTCAATAATGGCATTAGCGTCCGTAA
AACGGCTCACAATTTCACCGGTACGACGCGTCGCGAAAAAAGACATTGGCAGTTCAAAAATGTGTTTGATATA
AGACAAAATAATATCAATTGAGAGGCGTTGCCCCATGACAATTAATAAATAATCTCTGGCATAAGAGAGCAGT
TGTTGGATAACATACGCAAAAATAAGGCCTAGTGACACAATCCCTAGGGTGTTTTTCATGTTATCGGGGATAT
AGGTATCAATGATACCTTGCAAATAATATGATCCTAAAATACTCACTAGGGTAACCAACAAGGCAGCAATGAC
AATATTGATAACTAATAATTTTTGACGCGTAATCACTGGAATAAAAGAAGTCAAGGAACGCTTTTTATCCTTT
GTTGGCTTGTAGGTTGGATTGGGCGCAATAAAAATGGACACACCGGTCCACTCCTCATTAAAATGCGCTTTTG
TCATTTTATTTTTACCAACGGTATTATCTGGATCAGCGATTAATAGCTGATCACCTTTGATCCCATAAACTAC
ATAATAATGCGGGTATtTACCGTCTTTAATGACATGGGCGATAAAAGGATAGGGTAAATCCTTTTTATCGAAT
AAACTCAAATCAGCcTGGATCGGCATGGTTTCAAAGTCTAGCGCATTCGCAGCTTTAACAATGCCTAAAGCAG
TCGTTCCTTCCATGTCAGTTTTGGCCAGGTCCCGTAGTTTGGCTAAGGACAGGCGTGTTTTGTAATGAGTTAA
AACCATAGCGAGTGCAGCAACACCACAATCACGTTCATCTACTTGTGCGATATAATTTATTCTTTTTTGAAAC
ATTTTGACCTTAACCATTTTTAATTTGTTGATGATTGCTTGGAATGTTTTGAAATTAATTCGTCATTAATAGC
AGTAATCCATGCATTTATTGGTGTTTTAATTGTATAAATTGATAATCGTTTATAGTCCATGTTTCCATTAGTA
AAAATTAAAGAAGGCAGTTGAGAAATATTTAACTCTTGAAAGAAATTAATATAACTAGCTTTGTCAGAGGAAT
TATCTTTAAAAAAATTATCAACATTGAAGTACGCAACACGCATATTTTTGGTAGTCAAAATATCATGCAGCAT
GGGCAAAAATTTAACACAAATAGGACATGTCGGCCTGCCGAGGTAAATTAAACTGTCTTCTCCATTATTCATT
TTTTTATAAAAGTCAATGTATGATATTTTGTGAAACACATTCTTATCATCTGTCAATTTTTGATATTTGACAA
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CCACATCATCAGTTATGTTTAAATCTTGCATACCCTGTCTCCATTAAAAGTGAAATAATTAACAAATATAATT
TTAACATAAAACATAGAATTAATAAGTTAACATAAACATATTGATTTAGAATACCTTTAGATATATAATCGAA
TGTGAATTAAATAATATGAAAAGAGGAAAGTTATTATGATGAACATGAAACCTACGGAAAGCTATGAGCAATT
GGATAATAGTGCTCTCGAACAAGTTATTGGGGGGAAGAACTATGGAAACGGTGTTCACTGCACAAAAAAAGGA
TGCTCAGTTGATTGGGGCTATGCGTGGACCAACATCGCAAACAATTCAGTTATGAATGGCCTAACCGGTGGCA
ATGCTGGATGGCATAACTAAATTACTATGAAAATAAGATGGTTTTCTGGTGGAGAAGAACGTAAAAATTCTGC
TGTTCCCCTTATAGATGATTTAATCTCGGAATTGAATAAAAAGGATGACAATGAACCCGTGATTGTTGTGCTG
AATAAGTACAAAGATGAATTAATAAAAAAGGAAACATCTGTGCCATTTATTTTGAGTCGATTAAATGTAGATG
TTTCCAATGTTGTTAGAGATAATAATATTATTATGACAGACAAAGAAAGTGATATTTTGAGAGATATAAGAAA
ATTATCTAGTATTCGTTATGGATATTAGGTTTTGTTGTTCAAACGTTGGCATATTATTTGGAGAAATGTATCT
GTAACCATTATAGAATTAAAGGAACACTTTGGATGCTGATGCTTGCAAAAAAATCGAACTTTCCTTTGTCGTA
CTATATTAATCAGAATTTAAAATCAAAGCACATCTTAACATAATGTCGCTTATCTAAACTAAAAAGCGTCAAA
CCTTAAATAAACAGGGTTTGGCGCTTTTT 
 
